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ABSTRACT OF THE DISSERTATION
STUDY OF PROTEOFORMS, DNA AND COMPLEXES USING TRAPPED ION
MOBILITY SPECTROMETRY – MASS SPECTROMETRY
by
Alyssa L. Garabedian
Florida International University, 2018
Miami, Florida
Professor Francisco Fernández-Lima, Co-Major Professor
Professor Yuk-Ching Tse-Dinh, Co-Major Professor
The characterization of biomolecules and biomolecular complexes represents an
area of significant research activity because of the link between structure and function.
Drug development relies on structural information in order to target certain domains. Many
traditional biochemical techniques, however, are limited by their ability to characterize
only certain stable forms of a molecule. As a result, multidimensional approaches, such as
ion mobility mass spectrometry coupled to mass spectrometry (IMS-MS), are becoming
very attractive tools as they provide fast separation, detection and identification of
molecules, in addition to providing three-dimensional shape for structural elucidation. The
present work expands the use and application of trapped ion mobility spectrometry-coupled
to mass spectrometry (TIMS-MS) by analyzing a range of biomolecules (including
proteoforms, intrinsically disordered peptides, DNA and molecular complexes). The aim
is to i) evaluate the TIMS platform measuring sensitivity, selectivity, and separation of
targeted compounds, ii) pioneer new applications of TIMS for a more efficient and higher

vii

throughput methodologies for identification and characterization of biomolecular ions, and
iii) characterize the dynamics of selected biomolecules for insight into the folding
pathways and the intra-or intermolecular interactions that define their conformational
space.
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CHAPTER 1: INTRODUCTION

1

1.1 Overview
Interactions between proteins and DNA control several fundamental biological
processes, including gene regulation, replication, repair, transcription, translation and
recombination1. Studying complex formation and conformational changes as a function of
binding is a central goal in biochemical and biophysical research. The interaction between
such interfaces is crucial to understanding their potential as therapeutic targets and for
disease prevention.2 The basis of these interactions (e.g., association and dissociation) are
rooted in the kinetics and thermodynamics of the systems.3 Data from thermodynamic
studies (i.e., molecular modeling) have been successful in providing information on
binding free energies. However, because of the highly complex dynamics involved in
protein-DNA interactions there is still much ambiguity regarding the kinetic nature of the
folding process. As a result, extensive research has been dedicated to instrumental and
method development to further probe protein-DNA complex folding and allow detailed
insight into structural assembly.
Through the use of various techniques, structural elucidation of biomolecular
complexes have grown substantially;4 however, some significant limitations still exist.
Specifically, the heterogeneous nature and dynamic character of most assemblies and their
low relative concentrations within physiologically relevant conditions has provided
challenges for traditional structural biology tools. That is, high-resolution methodologies
(e.g., x-ray crystallography and NMR) dominate the field of structural biology because
they excel at revealing atomic level information. Unfortunately, their major limitation is
the requirement for large quantities of highly purified and homogenous samples. Even then,
such approaches can prove futile because of low sensitivity, lack of quality crystals, or the
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size of the molecular assembly. Additionally, in the case of x-ray crystallography, flexible
or disordered regions are often excluded and removed so that crystals can form for
analysis.5 Since between 30% and 50% of eukaryotic proteins have unstructured parts, the
majority of structural characterizations of eukaryotic proteins is incomplete. Even when
these efforts are successful, only a snapshot of the most stable biomolecule or biomolecular
complex conformation is described, which may not necessarily represent in vivo structures.
Thus, the inability to access information regarding kinetic intermediates at native
conditions means that a comprehensive view and significant portion of potential knowledge
is left inaccessible.
It is important, during the structural characterization of biomolecules, to preserve
the biologically relevant concentrations and conditions. Proteins can be heavily influenced
by their cellular environment, often being altered to some degree by post-translational
modifications (PTMs) to carry out specific functions. Many of these modified or
unmodified biomolecules are expressed at very low concentrations (<picomolar),
therefore, most analytical and biochemical techniques are not effective at these detection
limits or are restricted to one-dimensional type of analysis. For example, methods that can
detect compounds will often lack the ability to determine structure. To further advance the
field of structural analysis there is a push for multidimensional approaches that can detect
low abundant biomolecules followed by identification, quantification and tertiary structure
characterization. Comprehensive cellular measurements alone can potentially allow
progress in protein biomarker discovery, where distinct molecular signatures can lend
insight into the presence of specific disease. Early and effective disease detection provides
a greater potential for successful therapeutic applications and such research is well
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complemented by structural analysis as protein folding (i.e., the arrangement of amino
acids in space) is imperative in the search for drug targets. 6-8
1.2 Analytical Methods for Molecular Ionization, Separation and Characterization
Recent innovations in speed, accuracy, and sensitivity have established mass
spectrometry (MS) methods as a key technology within the field of structural biology and
complex mixture analysis.9 Specifically, native MS techniques, which have been
developed over the last two decades, permit the structural interrogation of intact
biomolecules and biomolecular complexes at biologically relevant conditions, which are
not accessible by other methods.10-14 For example, electrospray ionization (ESI) is a soft
ionization technique that has become a standard method in clinical laboratories. The
successful application of ESI by John Fenn’s group in 1988 showed that large proteins
could successfully and very efficiently be transferred intact from solution to the gas
phase.15 Fenn’s work opened the door for significantly low detection limits (femtomolar)
and larger mass range of analytes (kDa). Also significant was the fact that noncovalent
interactions are preserved throughout the ionization process, allowing complexes to be
interrogated for stoichiometry studies.16-17
Over the past decade ESI has been combined with ion mobility spectrometry (IMS),
coupled to mass spectrometry (IMS-MS) to become an analytical research tool employed
in the study of the structure of gas-phase ions, as it provides a more dynamic view and
native-like folding information.18 Used as a gas-phase separation technique, traditional
IMS relies on the separation of ions as they drift in a bath of inert neutral molecules (e.g.,
N2 or He) under the influence of a weak electric field.19-21 The ion’s mobility gives
information on their size and shape via the momentum transfer ion-neutral collision cross
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section (CCS) and allows the identification of different ion conformations based on the
variation in size.22 Many different forms of IMS have been used in the analysis of biological
molecules, the most common being FAIMS,23 DT-IMS24 and TWIMS.25-26 While different
in the mode of operation, resolution and sensitivity, their implementation has allowed for
the study of isotopomers,27 proteins,28-29 protein complexes,5, 30-35 folding pathways,36-38
unstructured/intrinsically disordered proteins,39-43 as well as collisionally activated states
of peptides and proteins.34, 44-50 In addition to biomolecule activation, variations in starting
solvent conditions (e.g., pH, organic, and salt content) have become a traditional approach
for studying conformational folding via IMS following the fact that disruption of the
hydrogen bonding networks can provide complimentary information on protein
composition, connectivity and architecture.51 In addition to altering starting solvent
conditions, post translational modifications (PTMs) or single amino acid mutations can
impact the function and folding of many proteins or complexes. The influence of chemical
or environmental changes on biomolecule structure have gone relatively undocumented
because most methods are insensitive to residue mutations at critical junctions18. However,
with mass spectrometry coupled experiments, sensitive structural information can be
elucidated.
Ion mobility spectrometry has also been extensively employed in areas of trace
analysis for the detection of explosives and chemical warfare agents52-53 and has proven
itself to be an invaluable tool in field of proteomics, genomics, and metabolomics as a
result of the ability to differentiate and identify isomeric species in complex samples.19
Ultimately, in comparison to traditional LC-MS approaches, IMS has the ability to provide
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more sensitive detection and higher throughput analysis of biological standards and
complex biological matrices for biomarker identification.
In 2011, Dr. Francisco Fernandez-Lima, Dr. Desmond Kaplan and Dr. Melvin A.
Park. pioneered the development of a new IMS analyzer - Trapped Ion Mobility
Spectrometer (TIMS). Since then, collaborative efforts between Dr. Fernandez-Lima
research group, Dr. Melvin A. Park at Bruker Daltonics Inc. and others have allowed for
major breakthroughs in the field of analytical chemistry. The possibility of decoupling the
time domain from the IMS separation allows for the study of conformationally trapped
molecular ions in the gas-phase as a function of the desolvation time, temperature and bath
gas composition. In the case of structural biology, the gas-phase studies take advantage of
the desolvation process to effectively reduce sample complexity, permitting molecular
characterization in the absence of bulk solvent. Trapped ion mobility spectrometry-mass
spectrometry has proven to consistently achieve high resolution and high mobility
separation; it boasts unparalleled resolving power up to ~400,54 compared to a typical
TWIMS and DT-IMS analyzer which will achieve ~30-60 and ~60-80. The new
capabilities for fast separation, identification, and quantification of complex mixtures, and
the ability to study biomolecular conformational space for structural elucidation makes
TIMS an exceptional platform. In particular, multiple molecules and their conformations
can be measured simultaneously, allowing it to be applied to a variety of analytical
challenges and questions. Kinetic studies can be performed to elucidate conformational
interconversion/intermediates of proteins and their complexes.55-62 When complemented
with molecular dynamics (MD), or other solution- and condensed-phase techniques, TIMS-
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MS has proven itself to be a very powerful instrument for biomolecule structural
characterization, and a leading technique in terms of speed and selectivity.
1.3 Dissertation Structure
This dissertation contains some research that has been published in peer-reviewed
journals. Specifically, material from chapter 2 was published in the Journal of the American
Society for Mass Spectrometry and published on their website (DOI: 10.1007/s13361-0171787-8). Chapter 3 was published in Analytical Chemistry (Anal. Chem., 2018, 90 (4), pp
2918-2925). Chapter 4 was accepted for publication in the International Journal for Ion
Mobility Spectrometry. Chapter 5 was published in Physical Chemistry Chemical Physics
(Phys. Chem. Chem. Phys., 2016, 18 (38), pp 26691-26702). We aim to quickly submit
chapter 6 to the Journal of the American Chemical Society. Chapter 7 has been submitted
for review for publication in Scientific Reports. Chapter 8 is being prepared for submission
in Biophysics.
Throughout this dissertation we combine several objectives that aim to understand
and develop new TIMS-MS capabilities, including complex mixture separation for
discovery and targeted molecular monitoring and quantitation, structural characterization
of intrinsically disordered peptides, DNA, proteins, and protein-DNA assemblies.
Complemented by extensive solution- and gas-phase experimental and computational
approaches, the goal was to pioneer new applications of TIMS for a more efficient and
higher throughput methodologies for identification and characterization of biomolecular
ions. In Chapter 2, we detail the first report on TIMS-CID-MS capabilities for offline
discovery and targeted monitoring of potential peptide biomarkers using data independent
mobility fragmentation and quantitation with internal heavy standards. The first analytical
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separation of isomeric, middle down, histone tail proteoforms using TIMS-MS is shown in
Chapter 3; this chapter also describes the first comparison across FAIMS, TWIMS and
TIMS platforms and the analytical potential of using FAIMS and TIMS due to their
substantial orthogonality. In Chapter 4, for the first time, TIMS-MS was applied to the
study of intrinsically disordered AT-hook peptides (ATHPs 1, 2 and 3) as a function of the
time after desolvation, organic content and bath gas composition; this study describes the
influence of the molecular environment on the conformational populations of intrinsically
disordered peptides. In Chapter 5, the first application of TIMS-MS for the study of DNA
conformers, specifically the kinetically trapped intermediate structures of i-motif DNA in
their folded and unfolded states is shown. This study provided the intramolecular
interactions that are responsible for stabilizing the folding pathway and for the first time,
the possibility to manipulate conformational populations prior to TIMS-MS using
collisional induced activation (CIA-TIMS-MS). In Chapter 6, we describe for the first time,
the interaction of intrinsically disordered peptides with DNA (ATHP with AT-rich DNA
hairpin) and demonstrated that the ATHP peptides can effectively bind to both the major
and minor DNA grooves. Chapter 7 provided for the first time an analytical workflow that
combines single amino acid substitutions with TIMS-MS for direct assignment of
intramolecular interactions and cis/trans locations in the ATHPs, as well as primary
sequence influence on the binding dynamics to AT-rich DNA. In chapter 8, for the first
time, the conformational space and binding dynamics to single stranded DNA and a stem
loop DNA of two topoisomerases – E.coli Topoisomerase IA and Vaccinia Topoisomerase
IB using TIMS-MS are described.
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2.1 Abstract
In the present work, the potential of Trapped Ion Mobility Spectrometry coupled to
TOF Mass Spectrometry (TIMS-TOF MS) for discovery and targeted monitoring of
peptide biomarkers from human-in-mouse xenograft tumor tissue was evaluated. In
particular, a TIMS-MS workflow was developed for the detection and quantification of
peptide biomarkers using internal heavy analogs, taking advantage of the high mobility
resolution (R = 150 – 250) prior to mass analysis. Five peptide biomarkers were separated,
identified and quantified using offline nanoESI-TIMS-CID-TOF MS and results were in
good agreement with measurements using a traditional LC-ESI-MS/MS proteomics
workflow. The TIMS-TOF MS analysis permitted peptide biomarker detection based on
accurate mobility, mass measurements, and high sequence coverage for concentrations in
the 10-200 nM range, while simultaneously achieving discovery measurements.
2.2 Introduction
The level of chemical complexity during proteomic analysis and the large dynamic
range of commonly studied and potential biomarkers represents an analytical challenge
that requires the further development of high throughput, orthogonal, reproducible and
robust analytical platforms. Nowadays, mass spectrometry based analysis offers an
unparalleled, non-targeted, analysis tool for dissecting complex protein samples at the
molecular level; however, prior to mass spectrometry analysis, pre-separation techniques,
such as high performance liquid chromatography (HPLC) and nano-liquid chromatography
(nanoLC), are often required to mitigate matrix effects and to enhance the peak capacity of
the analysis. These pre-separation methods have the advantage of reducing problems
associated with ion suppression during competitive ionization of complex samples, a
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phenomenon that is more typically observed during direct infusion ionization analyses [1,
2]. However, traditional LC-based protocols require long separation times in order to
analytically separate most of the compounds of interest, and high solvent volumes per
sample; which for large scale profiling, represents a major obstacle in analysis due to added
time and cost [3-5]. In addition, these techniques still suffer from poor separation of
isobaric species, which significantly challenges protein sequencing and identification using
bottom-up appraches. These challenges become major hindrances for the analysis of a
complex biological system, such as cancer proteomic samples, which typically contain a
myriad of molecular species. In addition, large-scale profiling in bottom-up proteomics is
often limited by the sensitivity of the current mass spectrometry instruments to isolate and
detect parent and fragment ions during tandem MS analysis of complex mixtures [6]. For
example, current bottom-up proteomic strategies require the chemical treatment of samples
(i.e., trituration, protein extraction, enzymatic digest) prior to analysis which result in
highly complex mixtures which then require further separation and preparation prior to MS
analysis [7].
An alternative approach is the use of gas-phase, post-ionization separations such as
ion mobility spectrometry coupled to mass spectrometry (IMS-MS), which promises
further gains in the speed, sensitivity and selectivity for the analysis of complex biological
mixtures [8, 9]. Specifically, the added mobility dimension of separation yields an increase
in peak coverage [6, 10-12], a factor that has often inhibited the analysis of complex
mixtures with MS-only detection. The IMS-MS coupling readily enhances peptide/protein
coverage and identification by allowing more ions, specifically isomers, to be resolved
while simultaneously reducing chemical noise [13, 14]. Previous studies have illustrated
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the advantages of IMS-MS in terms of profiling mixtures [8, 15-19], making it one of the
most powerful platforms for identification and characterization of proteins and peptides in
biological samples. Our group has been working on the development of alternative, timeindependent IMS approaches based on Trapped Ion Mobility Spectrometry coupled to MS
(TIMS-TOF MS and TIMS-FT-ICR MS) for the study and manipulation of gas-phase
molecular ions [10, 20-33]. Briefly, the concept behind TIMS is the use of an electric field
to hold ions stationary against a moving gas, so that the drift force is compensated by the
electric field and ion packets are separated based on their respective ion mobilities [20, 21,
27]. This concept follows the idea of a parallel flow ion mobility analyzer [34], with the
main difference that ions are also confined radially using a quadrupolar field to guarantee
higher ion transmission and sensitivity [20, 21]. Since the introduction of TIMS-MS in
2011 [20, 21], our group [10, 22-33, 35] and others [8, 36-44] have shown the potential of
TIMS-MS for fast, gas-phase separation and for molecular structural elucidation. In
particular, we have demonstrated the advantages of TIMS over traditional IMS analyzers
for fast screening [22] and targeted [10, 35] analysis of molecular ions from complex
chemical mixtures; the study of isomerization kinetics of small molecules [23, 24], peptides
[25], DNA [33], proteins [28, 29], DNA-protein complexes and protein-protein complexes
in their native and denatured states [32]. In a more recent report, we showed the isomer
separation of polybrominated diphenyl ether metabolites using nanoESI-TIMS-TOF MS
with mobility resolutions of up to 400 (the highest reported mobility resolution for singly
charged species) [30].
Herein, we present for the first time a nanoESI-TIMS-CID-TOF MS workflow,
developed for fast, gas-phase ion separation and accumulation, with efforts focused on
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targeted quantitative analysis and discovery measurements of breast cancer markers. The
ability of TIMS-CID-TOF MS to separate and sequence isobaric peptides in a complex
mixture is illustrated. We address typical challenges and targeted and discovery monitoring
strategies using isotopically-labeled internal standards for effective peptide identification
and sequencing. While LC-TIMS-MS separations has been recently shown in the case of
peptide markers [8], the presented workflow targets offline separations in order to shorten
the MS analysis time while tailoring the TIMS analysis for high mobility separation and
sensitivity.
2.3 Experimental
2.3.1 Tumor protein extraction and tryptic digestion
A patient-derived mouse xenograft model of luminal B human breast cancer Washington University Human-in-Mouse (WHIM16) was used for all the studies [45]. The
WHIM16 xenograft tumor pieces were transferred into pre-cooled Covaris Tissue-Tube 1
Extra (TT01xt) bags (Covaris no. 520007) and processed in a Covaris CP02 Cryoprep
device using an impact setting of 3 (all tumor tissue wet weights were less than 100 mg).
The tissue powder was then transferred into precooled cryovials (Corning no. 430487). All
procedures were carried out on dry ice and liquid nitrogen to maintain tissue in a powdered,
frozen state. Approximately 50 mg of WHIM16 tumor tissue was homogenized in 600 µL
of lysis buffer (8 M urea, 100 mM NH4HCO3, pH 7.8, 0.1% NP-40, 0.5% sodium
deoxycholate, 10 mM NaF, phosphatase inhibitor cocktails 2 and 3, 20 µM PUGNAc).
Protein concentrations of tissue lysates were determined by BCA assay (Pierce). Proteins
were reduced with 5 mM dithiothreitol for 1 h at 37 °C, and subsequently alkylated with
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10 mM iodoacetamide for 1 hour at room temperature in the dark. Samples were diluted
1:2 with Nanopure water, 1 mM CaCl2 and digested with sequencing grade modified
trypsin (Promega, V5113) at 1:50 enzyme‐to‐substrate ratio. After 4 h of digestion at 37
°C, samples were diluted 1:4 with the same buffers and another aliquot of the same amount
of trypsin was added to the samples and further incubated at room temperature overnight
(~16 h). The digested samples were then acidified with 10% trifluoroacetic acid to ~pH 3.
Tryptic peptides were desalted on strong cation exchange (SCX) SPE (SUPELCO,
Discovery-SCX, 52685-U) and reversed-phase C18 SPE columns (SUPELCO Discovery,
52601-U) and dried using Speed-Vac.
2.3.2 Tryptic peptide fractionation
The tryptic peptide sample was separated on a Waters reversed phase XBridge C18
column (250 × 4.6 mm, 5-μm and protected by a 4.6 mm × 20 mm guard column) using an
Agilent 1200 HPLC System. After sample loading, the column was washed for 35 min
with 10 mM triethylammonium bicarbonate, pH 7.5(solvent A), before applying a 102-min
LC gradient in combination with 10 mM triethylammonium bicarbonate, pH 7.5, 90%
acetonitrile (solvent B). The LC gradient started with a linear increase to 10% B in 6 min,
then to 30% B in 86 min, 42.5% B in 10 min, 55% B in 5 min and 100% solvent B in
another 5 min. The flow rate was 0.5 mL/min. A total of 96 fractions were collected into
a 96 well plate throughout the LC gradient. These fractions were concatenated into 48
fractions by combining 2 fractions that are 48 fractions apart (i.e., combining fractions #1
and #49; #2 and #50; and so on)[46]. The concatenated fractions were dried in a SpeedVac and stored at −80°C. Fractions of various volumes were prepared at PNNL based upon
BCA analyses to have total peptide concentrations of 0.5 µg/µL and shipped for analysis
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at FIU. Each fraction was selected based on LC-MS/MS analyses conducted at PNNL (to
be reported separately) to contain specific peptides to target for identification in those
analyses (see Table 1). Heavy standards of the target peptides were purchased from
ThermoFisher and used as received. The last residue of the sequence (Arg or Lys) was
modified with
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C6 and

15

N4 or

13

C6 and
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N2, respectively. Light (non-isotopically

labelled) standards of the target peptides were also purchased from GenScript and used
without further purification. All samples were diluted with Optima grade 0.1% Formic
Acid.
2.3.3 Trapped Ion Mobility Spectrometry – Mass Spectrometry Analysis
Individual fractions, each spiked with the corresponding internal heavy peptide
standard, were analyzed by directly infusing the sample via nanoESI into the TIMS-MS
spectrometer. A detailed overview of the TIMS analyzer and its operation can be found
elsewhere [20, 21, 27]. The nitrogen bath gas flow is defined by the pressure difference
between entrance funnel P1 = 1.8-2.6 mbar and the exit funnel P2 = 0.6-1.0 mbar at ca. 300
K. The TIMS analyzer is comprised of three regions: an entrance funnel, analyzer tunnel
(46 mm axial length), and exit funnel. A 880 kHz and 200 Vpp RF potential was applied
to each section creating a dipolar field in the funnel regions and a quadrupolar field inside
the tunnel. In TIMS operation, multiple ion species are trapped simultaneously at different
E values resulting from a voltage gradient applied across the TIMS tunnel. After
thermalization, species are eluted from the TIMS cell by decreasing the electric field in
stepwise decrements (referred to as the “ramp”) and can be described by a characteristic
voltage (i.e., Velution – Vout). Eluted ions are then mass analyzed and detected by a maXis
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impact Q-ToF MS (Bruker Daltonics Inc, Billerica, MA). In a TIMS device, the total
analysis time can be described as:
total IMS time = ttrap + (Velution/Vramp)*tramp + ToF = to + (Velut/Vramp)*tramp

(1)

where, ttrap is the thermalization/trapping time, ToF is the time after the mobility separation,
and Vramp and tramp are the voltage range and time required to vary the electric field,
respectively. The elution voltage was experimentally determined by varying the ramp time
(tramp = 100, 200, 300, 400 and 500 ms) for a constant ramp voltage. This procedure also
determines the time ions spend outside the separation region to (e.g., ion trapping and timeof-flight). The TIMS cell was operated using a fill/trap/ramp/wait sequence of 10/10/50500/50 ms. The ToF analyzer was operated at 10 kHz (m/z 100-3500). The data was
summed over 100 analysis cycles yielding an analysis time of ~50 s for the largest trapping
times (tramp=500 ms). Mobility calibration was performed using the Tuning Mix calibration
standard (G24221A, Agilent Technologies, Santa Clara, CA) in positive ion mode (e.g.,
m/z 322, K0 = 1.376 cm2 V-1 s-1 and m/z 622, K0 = 1.013 cm2 V-1 s-1) [27]. The TIMS
operation was controlled using in-house software, written in National Instruments Lab
VIEW, and synchronized with the maXis Impact Q-ToF acquisition program [20]. A
custom-built source using pulled capillary nanoESI emitters was utilized for all the
experiments. Quartz glass capillaries (O.D.: 1.0 mm and I.D.: 0.70 mm) were pulled
utilizing a P-2000 micropipette laser puller (Sutter Instruments, Novato, CA) and loaded
with 10 L aliquot of the 20x diluted sample solution. A typical nanoESI source voltage
of +600-1200 V was applied between the pulled capillary tips and the TIMS-MS instrument
inlet. Ions were introduced via a stainless steel inlet capillary (1/16 x 0.020’’, IDEX Health
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Science, Oak Harbor, WA) held at room temperature into the TIMS cell. Reduced mobility
values (K0) were correlated with Collisional cross section (Ω) using the equation:

Ω=

(18𝜋)1/2
16

𝑧

(𝑘𝐵

1

1 1/2 1 1

[ +𝑚 ]
𝑇)1/2 𝑚
𝑖

𝑏

(2)

𝐾0 𝑁 ∗

where z is the charge of the ion, kB is the Boltzmann constant, N* is the number density
and mI and mb refer to the masses of the ion and bath gas, respectively [47]. All resolving
power (R = Ω/ΔΩ) values were determined from Gaussian peak fits using OriginPro
(version 8.0).
2.3.5 LC-ESI-MS/MS Analysis
Confirmation studies using tandem mass spectrometry were performed by a
QTRAP 5500 Triple-Quadrupole mass spectrometer (AB Sciex, Concord, Ontario,
Canada) equipped with a Turbo V ion source (ESI) operated in the positive mode.
Solutions of peptides and heavy analogs (5.0 µM) in 50% acetonitrile, 0.1% formic acid in
water were directly infused (10 µL/min) into the TurboV ion source. Once suitable species
(usually [M+2H]+2) were detected in manual tuning mode, automatic optimization was
performed of the collision energy (CE), declustering potential (DP) and collision cell exit
potential (CXP) to obtain best parameters for MS/MS via collision-induced dissociation
(CID). A multiple reaction monitoring (MRM) detection method was thus developed for
each peptide and heavy analog, using the two most intense transitions observed for
quantitative and confirmation purposes. HPLC separations (40 µL injections) used a
reverse phase column (Dionex Acclaim 120 C18 Column, 250x2.1 mm, 5 µm) and a
Shimadzu Prominence LC-20AD Ultra-Fast Liquid Chromatograph. Mobile phase
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gradient was performed between 0.1% formic acid dissolved in water (mobile phase A)
and 0.1% formic acid dissolved in acetonitrile (mobile phase B), all purchased
commercially and of Optima LC-MS grade. The auto sampler was kept at 4° C. Analysis
was performed at 35° C with a flow rate of 0.80 mL/min, according to the following 11.0
min program: hold 10% B for 0.25 min; ramp to 65% B in 4.5 min; ramp to 98% in 0.1
min; hold for 1.65 min; return to 10% B in 0.5 min; hold for 4 min until end.
2.4 Results and Discussion
Commonly used peptide biomarkers during detection of protein DJ-1 [48],
calmodulin [49], parafibromin [50, 51], MAP7 domain-containing protein 1 [52-54] and
membrane-associated progesterone receptor component 1 [55, 56] (sequences:
DVVICPDASLEDAKK, VFDKDGNGYISAAELR, TTILQSTGK, LSASTASELSPK,
DFTPAELR, respectively) were used in this study (see Table 2.1). The selection of the
targeted peptides was guided towards covering a diverse protein abundance range based on
previous analyses of the patient-derived breast cancer mouse xenograft tissue sample
(WHIM16) using LC-QQQ by the Clinical Proteomic Tumor Analysis Consortium
(CPTAC) [57]. Single peptide standards and their respective heavy versions were analyzed
using TIMS-MS in order to determine the charge state distribution (CSD) and collision
cross section (CCS) when sprayed from the same starting solvent conditions as those of the
WHIM16 tryptic digested fractions. Peptides DFTPAELR and TTILQSTGK showed
similar CSDs with the [M+H]+ producing the most abundant signal, while
LSASTASELSPK, VFDKDGNGYISAAELR, and DVVICPDASLEDAKK showed
larger abundance for the [M+2H]+2 charge state (Figure 2.1). In addition to targeting m/z
peaks, based on their abundance as a function of the charge state, a second criteria utilized

25

Figure 2.1. Typical mass spectra and IMS projection plots of the five targeted peptides of
interest. Notice the high mobility resolution obtained using nanoESI-TIMS-MS for singly
and doubly charged molecular ions.
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was the simplicity of the CCS profiles for the [M+H]+ and [M+2H]+2 charge states in order
to avoid potential interferences. A typical mobility resolving power of R ~ 200 was
obtained for the [M+H]+ and [M+2H]+2 charge states and CCS values correlate well with
previously identified peptide mobility trend lines observed during IMS-MS analysis [58].
Comparison of the IMS profiles of the targeted peptides and the heavy analogs present the
same distribution and CCS values (Table 2.1); moreover, an exception to this rule was
observed for CAM modified heavy analogs customized to prevent disulfide association.
For the latter, the confirmation and quantification was made based on the targeted and
heavy analog m/z and CCS value. The power of the TIMS-MS for peptide characterization
was further examined by sequencing two of the targeted peptides possessing the same
nominal mass (e.g., m/z 948.479 and m/z 948.536 for DFTPAELR and TTILQSTGK,
respectively). While traditional proteomics analysis is based on peptide identification using
MS/MS strategies, for TIMS-CID-TOF MS the m/z and CCS characterization of the parent
ion can be complemented with CID without the need for m/z preselection if separation in
the CCS domain is achieved (Figure 2.2). Inspection of the experimental 2D IMS-MS
contour plots of the isobaric peptide mixture shows the fragment ions of DFTPAELR and
TTILQSTGK peptides falling directly in line with the mobilities of their respective parent
ion (Figure 2.2a). The incorporation of IMS prior to CID holds multiple advantages for
molecular identification since direct correlation of fragment ions with precursors ion can
be performed in the 2D-IMS-MS [59-65]. Analysis using TIMS provided baseline
separation of the targeted peptides, where a minimum RIMS~ 100 (i.e., CCS of 295 and 298
Å2) was required (Figure 2.2b). Closer inspection of the product ions (mostly b and y type
fragments and some internal fragments) permitted the verification of the peptide sequences
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Figure 2.2. a) TIMS-CID-MS of isolated isobaric precursor ions for the DFTPAELR and
TTILQSTGK peptides and the corresponding ladder fragmentation pattern. B) Mobility
selected MS showing the separation of the precursor ions. C) CID spectra of the fragments
corresponding to DFTPAELR and TTILQSTGK.
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(Figure 2.2c). The advantage of this approach when compared to traditional LC-MS/MS
proteomics is that the CCS values (or profiles) of each parent and corresponding fragments
are common parameters and can be used as additional identification confirmation. That is,
the precursor and product ions will share the same CCS, while characteristic LC elution
times may depend on several experimental conditions and may not be as reproducible, nor
specific, to a given peptide. However, because the CCS is a property of the peptide parent
ion, the possibility to uniquely trap the mobility range of interest in a TIMS analyzer
significantly enhances the multiple reaction monitoring capabilities of the TIMS-MS
analyzer by ultimately reducing chemical noise and increasing the TIMS selectivity of the
parent and fragment ions.
Despite the LC pre-fractionation step, the samples of interest provided highly
complex spectra with multiple peaks present at the nominal mass level in the 2D-IMS-MS
domain (Figure 2.3a). The 2D IMS-MS contour plots showed that each fraction contained
two main trend lines, corresponding to singly and doubly charged species [8]. Closer
inspection confirmed that the TTILQSTGK [M+H]+ molecular ion (m/z 948.536) was
accompanied by two other compounds within 5 mDa, which are not distinctly separated in
the MS domain alone, despite the high resolution of the TOF analyzer (RMS ~20-40k).
When combined with TIMS analysis, however, the three signals can be easily separated,
distinguished, and identified (Figure 2.3b). Further comparison of the targeted peptide and
the corresponding heavy analog IMS projections of TTILQSTGK [M+H]+ (m/z 956.555)
confirmed the assignment in the 2D-IMS-MS contour plots (Figure 2.3c).
After verifying the TIMS-MS workflow for high reproducibility and accuracy in
measuring and identifying the targeted peptides from the WHIM16 tryptic digested
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Figure 2.3. a) Typical 2D-IMS-MS contour plot using nanoESI-TIMS-MS for a fraction
containing the target peptide TTILQSTGK. The 2D-IMS-MS profile highlights the
complexity of each fraction and shows the charge state specific trend lines. b) The 2D IMSMS at the level of nominal mass depicts the isomeric interferences in the region of the
targeted peptide and heavy analog. c) IMS projection plots for the targeted and
corresponding heavy peptide using 5mDa window show identical CCS values.
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fractions, the potential for quantitative analysis via TIMS-MS was evaluated. To mimic
matrix effects, one of the fractions, with confirmed absence of the target peptide, was
spiked with known concentrations of the light and heavy peptide standards. The use of
internal heavy standards accounted for variations in the nanoESI spray between
experiments and from sample to sample, as well as changes in the spraying conditions as a
function of time. Figure 4 shows a linear dependence between the TIMS peak area and the
sample concentration for the case of the TTILQSTGK [M+H]+ peptide (Figure 2.4a),
regardless of the TIMS trapping time (e.g., tramp = 100-500 ms) and analytical ramp slope
(Figure 2.4b). The robustness of this TIMS-MS quantitation procedure was also confirmed
for all the peptides of interest at the low concentration (e.g., 1, 5, 10 and 20 nM) and the
use of internal heavy peptide analogs accounted for all the potential nanoESI spray
variability (Figure 2.4c).
The analysis and quantitation of targeted compounds in complex mixtures using
direct infusion ESI (and nanoESI) can be subject to ion suppression effects [66, 67]. To
further evaluate this consequence, dilution (up to 20 times) of a WHIM16 tryptic digested
fraction with known spiked concentrations of targeted and heavy standards showed less
than 10% variability in the TIMS-MS quantification results (Figure 2.5a, top).
Complementary LC-ESI-MS/MS based traditional proteomic analyses of the same sample
showed similar ion suppression effects (Figure 2.5a, bottom).
The ultimate test for the TIMS-MS workflow consisted of blind analysis of
WHIM16 tryptic digested fractions known to have the targeted peptides. Briefly, the
highest concentration of the targeted peptide observed was for DFTPAELR at 182 ± 7.0
nM (364 fmol/µg), follow by TTILQSTGK peptide at 21.0 ± 5.0 nM (42 fmol/µg),
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Figure 2.4. a) Typical TIMS profiles of a pure heavy standard and in-fraction light peptide
standard (TTILQSTGK [M+H]+) as a function of the concentration. b) Trapping efficiency
of TIMS analysis illustrating that trapping time does not impact the calculated
concentration or linear response and c) Measured light peptide concentrations for each
targeted peptide, via TIMS-MS, in relation to the heavy analog displaying a linear
response.
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VFDKDGNGYISAAELR peptide at 16.0 ± 4.5 nM (32 fmol/µg), DVVICPDASLEDAKK
peptide at 18 ± 5.0 nM (35 fmol/µg) and LSASTASELSPK peptide at 17 ± 4.8 nM (33
fmol/µg). The results of the TIMS-MS quantification procedure and their comparison to
LC-ESI-MS/MS based traditional proteomic analyses of the same sample are summarized
in Figure 5b and Table 1. Overall, comparable results for targeted peptides per fraction
were observed using nanoESI-TIMS-MS and LC-ESI-MS/MS; moreover, it is worth
stating that while nanoESI-TIMS-MS was routinely done in five minutes, each LC-ESIMS/MS analysis typically required 20-25 minutes. In addition, while TIMS-MS
measurements were geared toward the separation, identification and quantitation of five
targeted peptides, simultaneously, discovery TIMS-MS measurements were collected
without compromising the targeted analysis. That is, the TIMS-MS analysis allowed for
the identification of multiple tryptic peptides (both targeted and untargeted) from the above
five specified proteins. For example, TIMS-MS data analysis revealed 15 to 60% protein
sequence coverage, using peptide IDs that were not initially targeted, over the various
fractions analyzed (see Appendix 3.2 and Appendix 3.1 in the Supporting Information).
While new biomarker detection is out of the scope the present study, it should be noted that
a posteriori screening (or discovery) of potential biomarkers of interest is an inherent
potential of the current TIMS-MS workflow. That is, the use of TIMS-MS workflow as a
broad measurement technique, concurrently with the targeted quantitative approach,
effectively reduces the problems associated with individual analyses and holds the
advantage of increasing proteome coverage and new biomarker detection while
maintaining speed, accuracy and sensitivity.
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Figure 2.5. a) Response curves for the LSASTASELSPK [M+2H]+2 peptide standards
analyzed in fraction (matrix effect) and in the blank via nanoESI-TIMS-MS and LC-QqQMS and b) comparisons of targeted peptide concentrations measured in fractions by
nanoESI-TIMS-MS and LC-QqQ-MS.
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Table 2.1. Peptide sequence, m/z of light and heavy peptides, ion-neutral collision cross
section (CCS) and total in-fraction peptide concentration of the five targeted peptides in
the fractions. LC-ESI-MS/MS concentrations using the 535.2 187.0 DA
(DVVICPDASLEDAKK), 585.7  201.1 Da (VFDKDGNGYISAAELR) and 474.9 
130.1 Da (TTILQSTGK) channels are denoted with an asterisk (*).

2.5 Conclusions
The demand for fast, accurate, and sensitive analytical tools for the detection and
quantification of biomolecules is increasing as a way to offset the challenge of drug
discovery and biomarker identification. While several strategies have been developed,
some current efforts are focused on reducing sample preparation and analysis time, while
increasing detection limits and peak capacity by using complementary, orthogonal
separation techniques. In the present work, the concepts of characterizing proteomes using
offline nanoESI-TIMS-MS were evaluated by performing targeted and discovery analysis
of cancer biomarkers from a human-in-mouse xenograft tumor tissue. Results showed that
targeted peptide separation, identification and sequencing can be performed based on
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accurate mobility, mass and fragmentation pattern measurements, and that peptide
quantitation can be routinely achieved utilizing heavy peptide analogs as internal standards.
The capacity of the TIMS analyzers for selective mobility trapping with high resolving
power increases the selectivity and sensitivity of the analysis and provides unique
advantages for offline targeted studies compared with traditional LC-ESI-MS-MS
proteomic strategies. A good agreement was obtained between the quantitation using
offline nanoESI-TIMS-MS and LC-ESI-MS/MS. This work serves as a stepping-stone and
proof of concept for quantitative proteomics of targeted peptides without the need for
online LC separation, an aspect that can significantly lower costs and lead to increased
sample throughput during targeted biomarker detection.
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CHAPTER 3: LINEAR AND DIFFERENTIAL ION MOBILITY SEPARATIONS OF
MIDDLE-DOWN PROTEOFORMS
This chapter was adapted with permission from Garabedian, A., et al. Analytical Chemistry, 2018,
90 (4), 2918-2925. Copyright 2018 American Chemical Society.
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3.1 Abstract
Comprehensive characterization of proteomes comprising the same proteins with
distinct post-translational modifications (PTMs) is a staggering challenge. Many such
proteoforms are isomers (localization variants) that require separation followed by topdown or middle-down mass spectrometric analyses, but condensed-phase separations are
ineffective in those size ranges. The variants for “middle-down” peptides were resolved by
differential ion mobility spectrometry (FAIMS), relying on the mobility increment at high
electric fields, but not previously by linear IMS on the basis of absolute mobility. We now
use complete histone tails with diverse PTMs on alternative sites to demonstrate that
highresolution linear IMS, here trapped IMS (TIMS), broadly resolves the variants of ∼50
residues in full or into binary mixtures quantifiable by tandem MS, largely thanks to
orthogonal separations across charge states. Separations using traveling-wave (TWIMS)
and/or involving various time scales and electrospray ionization source conditions are
similar (with lower resolution for TWIMS), showing the transferability of results across
linear IMS instruments. The linear IMS and FAIMS dimensions are substantially
orthogonal, suggesting FAIMS/IMS/MS as a powerful platform for proteoform analyses
3.2 Introduction
As the proteomics tools mature, the front line moves to characterizing proteoforms
and revealing the activitymodulating impacts of post-translational modifications
(PTMs).1−5 Many proteoforms feature different numbers or types of PTMs, detectable by
mass spectrometry (MS) on the basis of the mass increment.6 Others are isomers with
identical PTMs on different residues.7−9 Such “localization variants” are individually
distinguishable by unique fragments in tandem MS, particularly employing electron
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transfer dissociation (ETD) that severs the protein backbone while retaining weaker PTM
links.3,7,9−11 The conundrum is that multiple variants frequently coexist in cells, but MS/MS
cannot disentangle mixtures of more than two, as those with PTMs on internal sites yield
no unique fragments.12,13 This calls for variant separation at least to binary mixtures before
the MS/MS step.12−14 Liquid chromatography (LC) could resolve some variants for
peptides in the “bottom-up” mass range (<2.5 kDa) usual for tryptic digests,15 but not
“middle-down” peptides (2.5–10 kDa) or intact proteins. Unfortunately, splitting proteins
into peptides using proteases precludes global PTM mapping by obliterating the
proteoform-specific connectivity information between the modified peptides.9,16
This problem is most prominent for histones that combine exceptional importance
to life with great diversity of PTM types and sites.9,16-26 Histones (H2A, H2B, H3, and H4)
consisting of ∼100–140 residues are nucleosome core particles—the spools that store the
DNA in cell nuclei and regulate chromatin structure and function through dynamic
reversible PTMs including methylation (me), trimethylation (me3), acetylation (ac),
phosphorylation (p), and others.9,14,16-26 Permuting their order and modulating the site
occupation levels in this ”histone code” drastically alters the activity of the whole genome,
defined chromatin domains, genomic regions, and/or individual genes. Nearly all PTMs in
histones are on the enzymatically cleavable N-terminal domains (“tails”) protruding from
the nucleosome.16,24,25 The H3 tail of ∼50 residues is cleavable by the endoproteinase GluC, and its characterization approaches that of intact histone.23-25
A growing alternative to LC is ion mobility spectrometry (IMS), which is based on
the ion transport in gases driven by an electric field,27,28 with the key benefits of speed and
distinct (often superior) selectivity. Linear IMS27 measures the absolute ion mobility (K)
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at low field strength (E), whereas differential or field asymmetric waveform IMS
(FAIMS)28 relies on the difference between K at high and low E elicited by an asymmetric
waveform. That ΔK is less correlated29,30 to the ion mass (m) than K, rendering FAIMS
more orthogonal to MS than linear IMS is—by about 4-fold for many biomolecular classes
comprising peptides.31,32 Therefore, FAIMS commonly separates isomers better than linear
IMS of the same resolving power (R), including peptides with sequence inversions32 and
localization variants with diverse PTMs.14,33-37 In particular, complete histone tails and their
segments involving various PTMs and sites have been resolved.14,34,35
Linear IMS separations of such variants were limited to phosphopeptides under
∼1.5 kDa.38,39Expanding this capability to larger peptides and smaller PTMs is topical, as
linear IMS platforms can be more sensitive than high-definition FAIMS. They also
determine the collision cross section (Ω) unavailable from FAIMS,27,28 which may help
understanding and predicting the PTM-controlled differences in the stability of peptide
folds with implications for activity in vivo.40 Here we deploy linear IMS in the commercial
traveling wave (TWIMS)41-47 and trapped (TIMS)48-53 platforms to separate localization
variants for complete histone tails. The instrumental resolving power of TIMS can exceed
300, far over ∼50 with TWIMS.42,53,54 However, R for proteins in linear IMS has been
capped at ∼30 by peak broadening due to conformational multiplicity. 55,56 A critical
advantage of TIMS is achieving for some protein conformers the same peak width as that
for small peptides, as in FAIMS.52,57
We utilize the H3 variants investigated14 by FAIMS to compare performance and
evaluate the orthogonality between two dimensions for middle-down proteoforms. We also
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inspect the correlation between TWIMS and TIMS to gauge the transferability across linear
IMS platforms.
3.1 ESI-TWIMS-MS Instrumentation
In TWIMS,41-47 ions “surf” along a stack of addressable electrodes that create an
axial wave with spatial period L and radially confining rf field. We employed the Synapt
G2 system (Waters, Milford, MA), where exiting ions are injected into an orthogonal
reflectron time-of-flight (ToF) stage (resolving power RMS of 20000) and registered.42 As
isobaric ions have the same velocity under vacuum, their temporal separation at the
detector equals the difference of transit times (tT) through the IMS stage determined by
mobility. Unlike the case with drift-tube (DT) IMS, the tT(K) function is not reducible to
closed form.42 Hence, extracting K (to deduce the ion geometries by matching calculations
or preceding measurements) necessitates a multipoint calibration using standards and is
especially challenging for macromolecules because variable source conditions and field
heating prior to and during IMS separation affect the geometries of pertinent standards.4244

Still, Synapt has become the prevalent IMS/MS platform in proteomics and structural

Table 3.1. PTM localizations in H3 tail (ART3K4Q T6ARK9S10 TGGK14A PRK18QL
ATK23AA RK27S28AP ATGGV K36KPHR Y41RPGT VALRE)
PTM

Positions

me

K4, K9, K23

me3

K4, K9, K23, K27, K36

ac

K9, K14, K18, K27, K36

p

T3, T6, S10, S28, Y41
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biology.45-47 Here we look at the variant separations without assigning structures; thus,
the tT scale was not converted into Ω terms. However, as in FAIMS,14 an internal
calibrant—a peptide of similar mass (insulin, 5.8 kDa)—was spiked to validate consistency
and accurate spectral comparisons. The spectra were linearly scaled to align the tT for
calibrant peaks.
The key parameters of TWIMS are peak voltage (U), wave speed (s), and the buffer gas
identity, pressure (P), and temperature (T).42 Separations are mainly governed by the ion
drift velocity at wavefront relative to its speed:
c = KU/Ls = K0P0TU/(PT0Ls)

(1)

where the subscript “0” denotes quantities at STP (including the reduced mobility K0). The
resolution is maximized at some c; therefore, the variants with unequal mobility (reflecting
different geometries and/or charge states z involved) may separate best in differing
regimes. However, the said maximum is near-flat over c ≈ 0.3–0.8, allowing ∼4-fold
variation of K with little resolution loss.42 The mobilities of large peptides with z > 3
depend on z weakly, as charging induces unfolding (elevating Ω), and the mobility range
for conformers at a given z is limited as well.56,59 Hence, peptides in different charge states
can often be run together. Ions in TWIMS are materially field-heated, which may isomerize
flexible macromolecules with mobility shifting over time.42,60 As reducing c slows the ion
transit,42 that effect may influence the variant resolution for large peptides apart from its
dependence on c for fixed geometries. Therefore, we have repeated analyses over the
practical c range using s values of 650, 1000, and 1900 m/s at U= 40 V with N2 gas at P =
2.2 Torr. The gas flows were 0.5 L/min N2 to the source (at 100 °C), 0.09 L/min N2 to the
(unheated) cell, and 0.18 L/min He to the helium gate in front of it.
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The ESI source with a 32-gauge steel emitter was run with the infusion flow rate of
20 μL/min, capillary at 2.8 kV, and sampling cone at 45 V. The geometries of protein and
peptide ions from ESI may keep the memory of folding in solution and thus depend on the

Figure 3.1. TWIMS spectra for histone tail variants with z = 6 - 11, measured with solvent
(i) using s = 650 m/s
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solvent,61,62 modifying the variant resolution. To assess that, we tested 0.1 μM peptide
solutions in (i) default 50/49/1 MeOH/H2O/acetic acid (pH = 3), (ii) predominantly organic
90/9/1 MeOH/H2O/acetic acid, (iii) extremely acidic 97/3 H2O/formic acid (pH 1.5), and
(iv) 99/1 isopropyl alcohol/acetic acid.
The apparent TWIMS resolving power is R = tT/w, where w is the full peak width
at half-maximum. The true R is greater by the logarithmic derivative of tT(Ω), which is ∼2
over the practical c range where tT(Ω) is near-quadratic.42,54
3.2 nESI-TIMS-MS Instrumentation
In TIMS,48-53 ions radially confined by rf field in a straight section of
electrodynamic funnel are axially stratified by flowing gas (sucked by MS vacuum) and
retarding longitudinal dc field E. As Eis ramped down, the flow pushes ions in order of
decreasing mobility to the MS stage—here, an Impact Q-ToF (Bruker, Billerica, MA)
with RMS = 30000 (at 10 kHz frequency). Separations depend on the gas flow velocity (vg),
trapping voltage (Vramp), base voltage (Vout), and ramp duration (tramp). Isomers emerge at
elution voltages (Velution) given by
K = vg/E = A/(Velution – Vout)

(2)

where A is a constant fit using internal calibrants52 (here the Agilent Tuning Mix
components with K0 values of 1.013, 0.835, and 0.740 cm2/(V s) for respective m/z values
of 622, 922, and 1222) with Velution for each determined from the analysis time corrected
for delay after elution (using varying ramp times).50 All electrode voltages were managed
by custom software synchronized with the MS platform controls. The rf amplitude was 250
VPP at 880 kHz frequency. The typical dc voltages were: inlet capillary at 40 V, funnel
entrance at 0 V, Vramp = −(50–200) V, and Vout = 60 V. Lower scan rates (Sr = ΔVramp/tramp)
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improve the resolving power; we generally adopted Sr = 0.3 V/ms. The overall
fill/trap/ramp/wait sequence was 10/10/(100–500)/50 ms. With summation of 100 cycles,
the longest acquisition took ∼1 min.
The buffer gas was N2, with vg set by the difference between pressures at the funnel
entrance (2.6 Torr) and exit (1.0 Torr). Ions were generated by a pulled-tip nESI emitter
(biased at 700–1200 V) from 10 μL sample aliquots (0.5 μM in (v) 50/50 MeOH/H2O or
(vi) H2O) and introduced into the TIMS device via an orthogonal unheated metal capillary.
More details on the nESI/TIMS hardware and mobility calibration are given in
the Supporting Information.
The measured mobilities were turned into Ω using the Mason-Schamp formula63;
3

2𝜋

𝛺 = 16 [(𝑘

𝐵 𝑇)

1

1

𝑧𝑒

(𝑚 + 𝑀)]1/2 𝑁𝐾

(3)

where z is the charge state, e is the elementary charge, kB is the Boltzmann constant,
and N and M are the gas number density and molecular mass, respectively. The resolving
power is51 R = Ω/w.
3.3 Results and Discussion
3.3.1 TWIMS Separations
Using solvent (i), we observed all variants in z = 5–11. This range is lower than
the z = 8–12 examined in nESI/FAIMS experiments with the same solvent,14 which reflects
a different ion source and greater instrumental sensitivity that allows collecting IMS data
for more states (although with low signal at z = 5).
Most IMS spectra were obtained using the default s = 650 m/s (Figure 3.1). Each
variant exhibits one defined peak in z = 10, 11 but up to three (fully or partly resolved)
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Figure 3.2. Relative (approximate) cross sections for K9me3 (dominant peaks). Lines guide
the eye through trends below and above the transition region. Data for K9ac are in
Appendix 3.2.
peaks in z = 6–9. This suggests a gradual transition from compact conformers at low z to
unfolded conformers at high zover several charge states exhibiting rich structural
heterogeneity, ubiquitous for proteins.56,59As the scaling42 of tT as ∼Ω2 renders Ω about
proportional to z(tT)1/2 over the practical tT range, we can estimate relative Ω with no scale
anchoring (Figure 3.2 and Appendix 3.2). The S shape of these plots with a jump between
two trend lines for all variants confirms unfolding at intermediate charge states. The
apparent R is 29–33 for all PTMs (average over variants and charge states) and 30–34 in z =
7 and 9–11 (average over variants and PTMs). In z = 8, the slightly wider peaks and
lower R = 27 likely reflect unresolved conformers broadening the peaks in unfolding
region. Hence, the performance is consistent across PTMs, their locations, and charge
states.
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The spectra for variants in many charge states significantly differ, but rarely enough
for satisfactory resolution. The greatest separation is for me3 tails, proven using the
mixtures of two to five variants (Appendix 3.3a-d). The best resolution is in z = 6, 8, 9: at
the peak apexes, K23me3 is largely resolved from all but K27me3 as 8+ ions and all but
K36me3 as 9+, K27me3 is largely resolved from all but K23me3 or K36me3 as 8+, and
K36me3 is baseline-resolved from others as 6+ and 9+. K9me3 is filtered from others in z =
10, 11 (not at the apex). As MS/MS can fully characterize binary variant mixtures, this
partial resolution helps more than may seem: for example, one can use 10+ or 11+ to detect
and reasonably quantify K9me3, 8+ for K27me3 (in K27me3/K36me3 mix), and 9+ for
K23me3 (in K23me3/K36me3 mix), while the K4me3 and K36me3 variants with PTMs
on bookend sites need no separation. This strategy demands no prior knowledge of the IMS
spectra for each variant, although that would accelerate analyses by revealing the optimum
drift times and charge states.
This successful separation was limited to the me3 case. For the isobaric acetylation,
no variant is fully resolved in any state. The K9ac and K36ac are filtered in 10+ at the
longest and shortest tT, respectively (with large signal loss), but separating those “bookend”
variants is not crucial. K14ac is enriched at the lesser peak in 9+, but intense contamination
by other variants makes that of little utility. The situation for phosphorylation is more
promising. One can cleanly filter the Y41p variant at its peak apex in 7+ and T3p and S10p
(away from apexes) in respectively 11+ and 10+, and T6p/S28p mix near the apex of S28p
in 6+ (the S10p contribution there would not compromise the analysis for T6p and S28p
with occupied external sites). For single methylation with just three variants here, the major
task is separating K9me with PTM in the middle. That is feasible (a bit off apex) in 10+
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and 11+, and the K4me variant can be filtered (away from the apex) in 10+. The profile for
K23me differs from those for K4me and K9me in 8+ and 9+ substantially, but not enough
for clean filtering. The separations for p and me variants are also verified using selected
mixtures (Appendix 3.3e-f).
The peak pattern in Figure 3.1 is consistent over the practical wave speed range:
raising s from 650 to 1000 and 1900 m/s increases tT from 4–7 to 6–10 and 10–25 ms
without significantly moving the relative peak positions (Figure 3.3 and Appendix 3.4). To
quantify, the tT sets at s values of 650 and 1000 m/s are correlated with r2 (average over all
charge states) of 0.95 for ac and 0.85 for me3, where the transitions between major
conformers at some z interfere with correlation (Appendix 3.5). The respective r2 values
for pairs at s = 1000 and 1900 m/s decrease to still high 0.90 and 0.79 (excluding one
outlier). Hence, the ion geometries are largely conserved between ∼5 and ∼20 ms. The
resolving power is unchanged at s = 1000 m/s (apparent R of 29–35 in z = 7, 9–11 and R =
25 in z = 8 upon averaging over all me3 and ac variants), but drops at s = 1900 m/s (to R =
17–28 in z = 7, 9–11 and R = 14 in z = 8). Thus, the variant resolution at s = 1000 m/s is
close to that at s = 650 m/s but deteriorates at s = 1900 m/s outside the optimum
range.42 Substitution of ESI solvent has minor effects on IMS spectra in any given charge
state (Appendix 3.6). This agrees with the analyses64 of unmodified histone tails using
Synapt G2, where the mobilities at fixed z were the same with solvent pHs of 2 and 6.5.
More acidic or organic media favor higher z as anticipated,64,65 and solvents (ii) and (iii)
produced me3 variants in z = 12 observed14 in FAIMS. However, we saw no significant
variant resolution for 12+ ions (Appendix 3.7). Hence, the variant separations by ESITWIMS are independent of the source and kinetic factors, likely reflecting the equilibrium
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Figure 3.3. TWIMS spectra for K27me3/K36me3 mix (z = 9) measured with solvent (i)
depending on the waveform speed (solid black lines), with fits by scaled individual traces
(colored lines) and their computed sum (dotted lines). Data for other speeds and mixtures
are in Appendix 3.4.
ion geometries formed in the desolvation region. Then overcoming insufficient variant
resolution requires IMS of higher resolving power, such as TIMS.
3.3.2 TIMS Separations
We observed z = 6–11 for all PTMs (K4me3 and K27me3 were not studied because
of sample shortage). The resolving power for base peaks at Sr = 0.3 V/ms is ∼80–280, with
a mean of ∼150–170 for each PTM. The overall average (R = 167) is >5× that with TWIMS
(R = 32), yielding multiple (up to ∼10) substantial peaks for all variants in each z except 6
and 10 (Figure 3.4 and Appendix 3.1). These metrics match those for multiply charged
unmodified peptides.66 We now note no drop of R in z = 8: instead of peak broadening,
multiple conformers produce rich spectra for all variants. The Ω values increase at
higher z due to unfolding, and relative Ω values match those estimated from TWIMS data
(Figure 3.2 and Appendix 3.2). This validates our approximation to obtain the relative Ω
from raw TWIMS spectra and points to similar ion geometries in the two separations.
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Figure 3.4. TIMS analysis of histone tail variants: spectra (cross section scale) for z= 6–11
(with solvent (v), tramp = 500 ms).
With the TIMS residence time of ∼40–400 ms (depending on tramp), even the
shortest is much beyond the longest in TWIMS. Gas-phase protein conformations may
evolve over time, specifically on the ∼5–500 ms scale relevant here.67,68 Present TIMS
experiments employed soft ion injection without activation. However, the IMS spectra for
all variants and charge states do not significantly depend on tramp or solvent (v) versus (vi)
(Figure 3.5 and Appendix 3.8). Therefore, we focus on the data obtained at maximum
resolution (tramp = 500 ms) using solvent (v), which provides a higher and more stable ion
signal.
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Figure 3.5. TIMS spectra for K23me3 8+ measured at (a) tramp = 100 and 500 ms from
solvent (v) and (b) tramp = 500 ms from solvents (v) and (vi). Results for
other tramp values, variants, and charge states are given in Appendix 3.8.
The three me3 variants can be largely separated using z = 6–9, 11 (Figure 3.4). One
can filter K36me3 from K9me3 and K23me3 best at the major peak c in 6+ and lesser a in
9+, largely K23me3 from others at the major peaks c in 8+ and b in 9+, and readily K9me3
from K36me3 in z= 6, 8, 9, 11. Resolving K9me3 from K23me3 is difficult: the best
outcome is a ∼3× enhancement in 8+ at the major peak d or e. However, separation to the
binary mixtures (by resolving the K9me3/K23me3 mix and K36me3) is trivial. As seen in
DTIMS and FAIMS analyses,14,38 the spectra are “quantized”: most variants exhibit
features at discrete Ω bands (labeled in Figure 3.4) in different proportions. This suggests
a set of energetically competitive folds persisting across variants, with relative energies
and thus populations dependent on the PTM position.
Despite many more features, these separations track the order and often the relative
spread of cross sections found in TWIMS (Figure 3.1): K9me3 ≤ K23me3 < K36me3 in
6+, similar Ω values for leftmost peaks with features c, d for K36me3 and (with higher
Ω) d for K23me3 in 7+, K36me3 < K23me3 < K9me3 for major peaks in 8+, and K9me3
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< K23me3 ≤ K36me3 for those in 11+. The starkest similarity is in 9+: here K9me3 has
one major peak d with feet b and c, K23me3 has three peaks (largest b, smallest c, and
medium d), K36me3 has two intense peaks (a and larger c), and the overall order is K36a <
K23b ∼ K9b < K36c ≤ K23c < K9d < K23d. The only difference is that in 10+ all variants
coincide in Figure 3.4 but K9me3 lies to the left of others in Figure 3.1.
The results for other PTMs are similar. With acetylation (Figure 3.4), there is
modest separation in 6+, but K9ac and K18ac are well-resolved from K14ac and K27ac
(and vice versa) at the peak apexes in 7+. The blow-up of conformational multiplicity in
8+ obstructs separations, but K27ac is filtered from others at f. The 9+ state permits
excellent resolution of K14ac from others at the major peak d and intense e (and vice versa
at the major peaks for others a, b, c) and of K9ac at bfrom K14ac and K27ac. Each variant
exhibits one major peak in 10+ as with the me3 case, but here those are dispersed enough
to resolve K9ac and K36ac from others at the apexes. In 11+, all variants are similar except
K36ac filtered at the major peak a. These properties permit multiple protocols to quantify
all variants in a mixture. The optimum may be to isolate K9ac in 10+, K14ac in 9+, K27ac
in 8+, and K36ac in 10+ or 11+ (not truly necessary for the bookends K9ac and K36ac).
K18ac is not resolved in any state individually but is resolved to binary mixtures
(K9ac/K18ac at the peak apex in 7+ and K18ac/K27ac right of the c apex in 9+), allowing
redundant quantification by ETD. The order of peaks across charge states also correlates
with TWIMS data. For example, that in 10+ is K36ac < K18ac ≤ K27ac < K14ac < K9ac
in TIMS and similar K36ac < K27ac ≤ K18ac = K14ac < K9ac in TWIMS (Figure 3.1).
With phosphorylation (Figure 3.4), one can pull out (at apexes) S28p and Y41p in
6+, T3p in 10+ and 11+, and S10p in 10+. As with ac variants, here one (T6p) is not cleanly
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resolved in any z but is filtered in T6p/S28p mix at the apex in 6+ and T6p/S10p mix at the
apex in 10+ (best) and peak i in 8+. Hence, all variants are quantifiable employing ETD.
The correlation with TWIMS data is clear: e.g., the peak order (Figure 3.1) is consistently
Y41p < S10p < T3p < T6p < S28p in 6+ and T3p < T6p < Y41p < S28p < S10p in 10+. As
with TWIMS, the separations projected from individual spectra were confirmed using
binary mixtures (Appendix 3.9).
With me variants, the spectra in z = 6–8 provide only a limited separation (Figure
3.4). We can filter K4me at the major peak apex in 10+ and (less cleanly) K23me at peak
a in 9+. The K9me is filtered from K4me right of the apex in z = 10 and (not cleanly) from
K23me on the left of the major peaks in 6+ or 11+. Thus, each variant can be filtered as an
individual or as a dominant component of binary mixtures. The correlation with TWIMS
data is seen from the peak order K9me < K4me < K23me in 11+ or intense peaks on the
left for only K23me in 8+ and 9+ (Figure 3.1).
3.3.3 Correlations between Separation Dimensions
The analyses of the same peptide set in FAIMS14 and two linear IMS systems allow
exploration of pairwise correlations between separations within and between those
dimensions: across charge states in TWIMS and TIMS and for the same species in the
TWIMS/TIMS/FAIMS space.
Separations of all variants in TWIMS notably differ across charge states. This may
be quantified via pairwise linear correlation between separation parameter sets. 14,34 Here,
the mean r2values for tT correlations over z = 5–11 (Appendix 3.10) equal 0.23, 0.24, and
0.25 for me3, ac, and p variants, respectively (with 21 pairs each). The values for Ω in
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TIMS are the same: 0.23 (ac variants) and 0.24 (p variants) for z = 6, 7, 10, 11 with single
dominant peaks (Appendix 3.11) and 0.26 and 0.18, respectively, if we add z = 8, 9 using
Table 3.2. Summary of Linear Correlations between Separations (averaged over all PTMs
and charge states): r2 values with Standard Errors of Mean.
TWIMS (z1)

TIMS (z1)

FAIMS (z1)

TWIMS (z1)

0.91 ±

0.03a

0.52 ± 0.10e

TWIMS (z2)

0.24 ± 0.04b

0.22 ± 0.05f

0.05c

0.52 ± 0.11g

TIMS (z1)
TIMS (z2)
FAIMS (z2)

0.86 ±

0.22 ± 0.03d

0.22 ± 0.04h
0.25 ± 0.05i

a. In TWIMS at s = 650 vs. 1000 m/s
b. In TWIMS for same peptides in different z
c. For same ion species in TWIMS vs. TIMS
d. In TIMS for same variants in different z
e. For same ion species in TWIMS vs. FAIMS (8 pairs)
f. For variants in TWIMS vs. same variants with different z in FAIMS (24 pairs)
g. For same ion species in TIMS vs. FAIMS (8 pairs)
h. For variants in TIMS vs. same variants with different z in FAIMS (24 pairs)
i. In FAIMS for same variants in different z (30 pairs).14
base peaks. The aggregate r2 over all PTMs is 0.24 ± 0.04 standard error (for 63 pairs) with
Synapt and likewise 0.22 ± 0.03 with TIMS, also equal to 0.25 ± 0.05 (for 30 pairs with z =
8–12 for me3, ac, and p variants) with14 FAIMS (Table 3.2). This manifests an essentially
perfect orthogonality across charge states, previously demonstrated in FAIMS14,34 but not
linear IMS separations of any PTM localization variants.
We can also quantify the correlation between TWIMS and TIMS seen in
comparisons of cross sections (Figure 3.2) and spectra (Figure 3.1 and 3.4) best for ac and
p variants with five tT and Ω points. Calculations for z = 8, 9 are complicated by multiple
intense features in both data sets that need integration; therefore, we restricted the
comparison to z = 6, 7, 10, 11 with at most two major peaks. The resulting r2 values
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(Appendix 3.12) are 0.7–1.0 (mean 0.76) for ac and 0.9–1.0 (mean 0.95) for p variants
(higher r2 values for the latter reflect a greater variant separation diminishing the relative
random error of peak spacings). These values with aggregate r2 = 0.86 ± 0.05 (Table 3.2)
show strong correlation, especially as we ignored the smaller features in TIMS spectra
and tT is not proportional to Ω. The accord between TWIMS and TIMS data despite
dissimilar ESI and ion heating regimes and ∼50× longer separation in TIMS shows the ion
geometries conserved over ∼5–300 ms and supports the formation of equilibrium
conformers in the source. The present similarity between TWIMS and TIMS separations
mirrors that for peptides with D/L residue swaps,66 though just two epimers per peptide
there allowed no r2 values.
This orthogonality of separations across charge states, their number generated by
ESI, and impressive resolving power enable TIMS to disentangle all variants tried to at
least the binary mixtures. That said, separation to individual variants would be beneficial.
Also, the histone stoichiometries have up to ∼50 known variants,69,70 with further less
abundant variants likely to be discovered. Fully characterizing such complex endogenous
samples involving spectral congestion requires yet greater peak capacity (pc) that could
come from 2-D FAIMS/IMS separations, depending on the orthogonality between
dimensions.
The complementarity of FAIMS and linear IMS separations of histone tails is
evident from different loci of variant resolution across charge states. For example, that for
me3 variants maximizes for z= 8, 9 in TWIMS (Figure 3.1) and TIMS (Figure 3.4) vs 10
and 11 in FAIMS.14 Within a given state, some variants resolved by FAIMS may coelute
in TIMS and vice versa. For instance, in z = 10, the K18ac and K27ac merged in TIMS are

62

separated by the FAIMS baseline,14 whereas TIMS partly resolves K14ac and K27ac
merged in FAIMS.14 Broadly, the FAIMS dimension is correlated to TWIMS/TIMS with
mean r2 (over z = 8–11) of 0.51/0.42 for ac and 0.53/0.60 for p variants (Figure 3.6 and

Figure 3.6. Linear correlations between FAIMS and TIMS separations for ac variants (r2
marked). The plots involving TWIMS and for p variants are in Appendix 3.14.

Appendix 3.13), with the aggregate of 0.52 ± 0.07 for 16 pairs (Table 3.2). Proteomic
findings are often validated by negative testing of a priori false suppositions using decoy
databases.71 Inspired by that, we computed the “decoy correlations” of FAIMS to
TWIMS/TIMS separations for same variants in all wrong charge states (48 pairs, Appendix
3.14). The associated mean r2 value of 0.22 ± 0.05 (with TWIMS or TIMS) is apart from
the above for correct states but matches the r2 for correlations across those in TWIMS or
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TIMS that apparently make the random baseline (Table 3.2). Therefore, the correlation
between linear IMS and FAIMS is real but is below 50% upon baseline subtraction.
Accordingly, the 2-D pc of FAIMS/IMS separations for middle-down peptides must be
over half of the product of pc for each stage (defined as the occupied separation space, d,
over mean w of peaks). Here in TIMS, the typical d ≈ 100 Å and w ≈ 10 Å in a “good”
charge state yield pc ∼10 (e.g., 8 for p variants in 6+ and 10+, or 14 and 11 for me3 variants
in 8+ and 9+). In FAIMS,14 the typical pc in one state was ∼25 (with d ≈ 30 V/cm and w ≈
1.2 V/cm). Hence, the pc of FAIMS/IMS would be >125 in one state and easily >500 in all
(near-orthogonal) states. The values would be greater for more complex samples (as the
separation space statistically widens), and the number of available charge states can be
augmented (e.g., via supercharging).72-74 Despite much of this pc taken up by the
conformers of each variant,14 it should still suffice to largely fractionate the known
isomeric proteoform sets at least into binary mixtures.
3.4 Conclusions
Linear IMS with resolving power >100 (specifically TIMS) can broadly separate
the PTM localization variants of “middle-down” peptides, here histone tails with ∼50
residues comprising common PTMs: methylation(s), acetylation, or phosphorylation.
Although only some variants (at best) are resolved in each charge state generated by ESI,
the separations are orthogonal across states and all variants were filtered in some to at least
binary mixtures quantifiable by ETD MS/MS. The serial Bruker timsToF Pro system
featuring another funnel trap prior to the TIMS cell would deliver similar separations with
improved sensitivity due to a higher duty cycle. The much lower resolving power of
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(commercial) TWIMS limits separation to a few variants, but all relative mobilities
reproduce those in TIMS despite dissimilar ESI and IMS conditions. Separations are also
independent of the ESI solvent or IMS residence time (from ∼5 to ∼300 ms), though less
denaturing solvents and/or conditions may change that. This suggests that we deal with
stable conformers thermalized prior to separation, wherein results transfer to other IMS
systems including DTIMS.75 This indicates cataloging the Ω values for all histone
proteoforms. However, ETD (with a normal time scale of ∼10–100 ms) is harder to add
after time-dispersive separations that output transient ion packets (such as DTIMS and
TWIMS) in comparison to TIMS, where the ramp can be arbitrarily slow. These findings
agree with those for D/L peptides66 but extend beyond ∼3 kDa considered there.
The linear IMS and FAIMS separations14 for same set of variants are ∼50%
orthogonal (as for tryptic peptides).76 Hence, online FAIMS/IMS based on existing
technology ought to provide a 2-D peak capacity of several hundred across charge states,
enabling separation of most complex known proteoform mixtures.
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CHAPTER 4: TAILORING PEPTIDE CONFORMATIONAL SPACE WITH
ORGANIC GAS MODIFIERS IN TIMS-MS
This chapter was published in International Journal of Ion Mobility Spectrometry and reproduced
with permission.
Garabedian, A., et al. Int. J. Ion Mobil. Spectrom. (2018). https://doi.org/10.1007/s12127-018-02315
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4.1 Abstract
Recently, we showed the advantages of Trapped Ion Mobility Spectrometry
for the study of kinetic intermediates of biomolecules as a function of the starting
solvent composition (e.g., organic content and pH) and collisional induced
activation. In the present work, we further characterize the influence of the bath
composition (e.g., organic content) on the conformational space of an intrinsically
disordered, DNA binding peptide: AT-hook 3 (Lys-Arg-Pro-Arg-Gly-Arg-Pro-ArgLys-Trp). Results show the dependence of the charge state distribution and mobility
profiles by doping the solution and the bath gas with organic modifiers (e.g.,
methanol and acetone). The high resolving power of the TIMS analyzer allowed the
separation of multiple IMS band per charge state, and their relative abundances are
described as a function of the experimental conditions. The use of gas modifiers
resulted in larger ion-neutral collision cross sections, with a direct correlation
between the size of the modifier and the CCS differences. Conformational isomer
inter-conversion rates were observed as a function of the trapping time. Different
from solution experiments, a larger variety of organic gas modifiers can be used to
tailor the peptide conformational space, since peptide precipitation is not a problem.
4.2 Introduction
Mass

spectrometry-based

methods

have

increasingly

become

a

complementary or alternative research tool for investigating the conformational
space of biomolecules under a variety of conditions, including biologically relevant
conditions.1-5 Specifically, ion mobility spectrometry combined with mass
spectrometry (IMS-MS) has the capability to perform separation and selection of
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gas-phase ions, from heterogeneous solutions. It provides insight into both stable
and intermediate structures, allowing for a more dynamic view and native-like
folding information,6 while resembling solution structures (memory effect). 7-15
Previous studies from our group showed the advantages of ESI-TIMS-MS for the
study of kinetically trapped intermediates of biomolecules.14, 16-26 Relevant to this
study, we presented the folding pathways between local, free energy minima of AThook peptide 3 (ATHP3) leading to multiple, stabilized conformations. 27
Protonation site, backbone relaxation and side-chain orientations were implicated in
defining each structure. We have shown that the conformational space can be altered
by introducing dopants into the TIMS cell for the case of flavin adenine
dinucleotide.26 Different from other experiments where gas modifiers are used to
increase the analytical power of IMS by increasing the size of the collision partner
or inducing higher order multi-pole interactions,28-33 in this project we focused on
the influence of the microenvironment on the stabilization of the conformational
space of biomolecules.
In the present work, a ten amino acid intrinsically disordered peptide, LysArg-Pro-Arg-Gly-Arg-Pro-Arg-Lys-Trp, was studied using nanoESI-TIMS-MS as
a function of starting solvent (e.g. organic content and pH), bath gas collision partner
and time after desolvation. This study is the first to report on the use of TIMS gas
modifiers to tailor the peptide conformational space.
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4.2 Experimental Methods
4.2.1. Materials and reagents
AT-hook peptides 3 (Lys-Arg-Pro-Arg-Gly-Arg-Pro-Arg-Lys-Trp) was
purchased from Advanced ChemTech Inc. (Louisville, KY) and used as received.
Methanol and acetone solvents, and ammonium acetate salts utilized in this study
were analytical grade or better and purchased from Fisher Scientific (Pittsburgh,
PA). A Tuning Mix calibration standard (G24221A) was obtained from Agilent
Technologies (Santa Clara, CA) and used as received.
4.2.2. Trapped Ion Mobility Spectrometry – Mass Spectrometry Analysis (TIMSMS).
Details regarding the TIMS operation and specifics compared to traditional
IMS can be found elsewhere. 34-38 Briefly, mobility separation in TIMS is based on
holding the ions stationary against a moving gas using an electric field. The
separation in a TIMS device can be described in the center of the mass reference
frame using the same principles as in a conventional IMS drift tube.39 Since mobility
separation is related to the number of ion-neutral collisions (or drift time in
traditional drift tube cells), the mobility separation in a TIMS device depends on the
bath gas drift velocity, ion confinement and ion elution parameters. The reduced
mobility, K, of an ion in a TIMS cell is described by:
𝐾=

𝑉𝑔
𝐴

𝐸 (𝑉𝑒𝑙𝑢𝑡𝑖𝑜𝑛 − 𝑉𝑜𝑢𝑡 )
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where vg and E are the velocity of the gas and the applied electric field across the
TIMS analyzer region. Velution is the voltage when the ions elute in the Vramp sweep
and Vout is the voltage applied at the end of the TIMS analyzer region.
A custom-built, pulled capillary nanoESI source was utilized for all the
experiments. Quartz glass capillaries (O.D.: 1.0 mm and I.D.: 0.70 mm) were pulled
utilizing a P-2000 micropipette laser puller (Sutter Instruments, Novato, CA) and
loaded with 10 L aliquot of the sample solution. A typical nanoESI source voltage
of +/- 600-1200 V was applied between the pulled capillary tips and the TIMS-MS
instrument inlet. Ions were introduced via a stainless steel tube (1/16 x 0.020’’,
IDEX Health Science, Oak Harbor, WA) held at room temperature into the TIMS
cell. It should be noted that all solvent studies were performed with nitrogen as the
bath gas, and that all dopant experiments were conducted with peptides sprayed from
10 mM NH4AC.
Mobility calibration was performed using the Tuning Mix calibration
standard (G24221A, Agilent Technologies, Santa Clara, CA) in positive ion mode
(e.g., m/z = 322, K0 = 1.376 cm2 V-1 s-1 and m/z = 622, K0 = 1.013 cm2 V-1 s-1).38 The
TIMS operation was controlled using in-house software, written in National
Instruments Lab VIEW, and synchronized with the maXis Impact Q-ToF acquisition
program.34-35 Gas modifiers were introduced at the entrance of the TIMS cell via
vaporization of the respective solvents (e.g., methanol or acetone) at a ratio of 2:1
air:air modified mix (scheme shown in Figure 4.1).

For simplified mobility

calibration, the gas velocity was kept constant in all experiments (P1 and P2 values).
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4.3 Results and Discussion
The analysis of ATHP3 peptide using nES-TIMS-MS resulted in a charge
state distribution of [M+H]+ to [M+3H]+3. The ATHP3 motif is mainly comprised
of basic residues with seven potential locations for protonation (e.g., N-terminus,

Figure 4.1. Scheme utilized for the nESI-TIMS-MS experiments with organic gas
modifiers. Notice that the gas velocity in the TIMS analyzer is kept constant
four arginines and two lysines), however, the most abundant ion under all
experimental conditions was the [M+2H]2+ charge state (Figure 4.2a). The mobility
distributions observed from our previous study of ATHP 3 [M+2H] +2 using ESITIMS-MS are consistent with the current analysis by nanoESI-TIMS-MS.27
At native conditions (Figure 4.2b, pink mobility bands) ATHP3 [M+2H]2+
populates four conformers (A-D). The mobility bands are also conserved across the
different organic solvent conditions (Figure 4.2c, pink mobility bands in blue panel).
At higher trapping times (e.g., 500 ms), a kinetically trapped structure, and what we
consider a more stable “desolvated” conformer, appears between bands B and C of
the native. The presence of methanol in the TIMS cell did not alter the [M+2H] 2+
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conformers, while acetone significantly changed the relative abundance and
distribution of structures (Figure 4.2d, pink mobility band in pink panel). Three
structures (A, B and C) were observed for ATHP3 [M+3H]3+ over the range of
starting solvent solutions (Figure 4.2b and 4.2c, green mobility bands). Conformer
A was the major structure present in all experiments, followed by conformer B and
C. The abundance of conformer B, however, increased in the presence of acetone in
the TIMS cell. The mobility profiles of ATHP3 [M+H]+ showed the presence of two
structures (A and B) which were observed over the range of experimental conditions
(Figure 4.2b, 4.2c and 4.2d, blue mobility bands). The distribution of ATHP 3
structures using acetone solvent cannot be recreated using acetone in the TIMS cell.
One possible explanation is that the differences in conformational space is due to
interaction with the ketone functional group of acetone. Unlike methanol’s alcohol
group, acetone’s ketone group can form various interactions with the peptide,
including 1) hydrogen bonding with the amide of the peptide backbone, 2) disruption
of hydrogen bonding networks or, more likely, 3) dipole-dipole interactions with the
charged residues of the peptide. Confirming this explanation will be the subject of
future studies.
Changes in the conformational space as a function of the trapping showed
stabilization towards more energetically favored structures as a function of the
trapping time for [M+H]+2 charge state (Figure 4.3). While our measurements are
only sensitive to the 50-500 ms time scale, potential rearrangements are possible in
the first 50 ms after desolvation40. In the case of varying the starting solution (10
mM ammonium acetate, and with methanol and acetone), a common trend in the gas
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phase kinetics in nitrogen is the increase of the band E, which corresponds to the
largest 1/K0 for this charge state. However, in the case of gas modifiers, band E is
not observed, and the trends are best characterized by a decrease

Figure 4.2. a) Typical mass spectra and b) native IMS spectra of ATHP3 as a function of
c) starting solvent (methanol:H2O or acetone:H2O) or d) dopant bath gas (methanol or
acetone).
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Figure 4.3. The relative abundances of ATHP 3 [M+2H]+2 conformers as a function of the
trapping time, stating solvent conditions and bath gas composition. Starting solvent and
bath gas are listed to the left of the graphs
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of band B and band A for methanol and acetone, respectively, which correspond to
the smallest 1/K0. We interpret these results as the most stable gas-phase structures
tending to have larger 1/K0 than those initially observed in solution. These effects
may be a consequence of the absence of the solvent, since in the gas-phase the lack
of water molecules promotes long range interactions. In the case of the [M+H] + and
[M+H]+3 charge states, similar trends were observed regarding the increase of larger
1/K0 bands as a function of the trapping time (see Figure 4.2).
4.4 Conclusions
The results presented here displayed the utility of gas modifiers in TIMS-MS for
investigating and monitoring solution versus gas-phase microenvironment contribution to
the peptide conformational space. When ionized from native conditions (10 mM NH 4Ac
and nitrogen bath gas), the mobility profiles of ATHP 3 show an ensemble of conformers,
which were preserved as a function of increasing organic content (methanol and acetone).
Although the overall IMS profiles were maintained, changes in the relative abundance of
conformers (e.g., conformational isomerization to the more stable gas-phase structure)
were observed and recorded. The interconversion of structures, however, was small and
often did not exceed growth or decay abundances of ~10%. Comparison between starting
solvent and bath gas with the same organic modifier showed that acetone as a dopant
consistently changed the original IMS profiles. We attribute these rearrangements to the
highly polar ketone functional group of acetone and its interaction with the peptide (i.e.,
disruption of the hydrogen bonding network or interaction with the charged residues).
Overall, we find evidence for multiple stable conformers of these “disordered” motifs as a
function of starting solvent (e.g. organic content), bath gas collision partner and time after
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desolvation. The sensitivity of TIMS-MS allows for the observation of many low abundant
conformers, separation of closely related structures and tracking of gas-phase stable
structures via isomerization kinetics. This methodology opens new avenues for the study
of biomolecules in the presence of gas modifiers that are not accessible during solution
experiments, due to the typical precipitation of biomolecules during non-native conditions.
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CHAPTER 5: STRUCTURES OF THE KINETICALLY TRAPPED I-MOTIF DNA
INTERMEDIATES
This chapter was reproduced from Garabedian, A., et al. Phys. Chem. Chem. Phys., 2016, 18 (38),
26691-26702 with permission from PCCP Owner Societies.
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5.1 Abstract
In the present work, the conformational dynamics and folding pathways of i-motif
DNA were studied in solution and in the gas-phase as a function of the solution pH
conditions using circular dichroism (CD), photoacoustic calorimetry analysis (PAC),
trapped ion mobility spectrometry - mass spectrometry (TIMS-MS), and molecular
dynamics (MD). Solution studies showed at thermodynamic equilibrium the existence of a
two-state folding mechanism, whereas during the pH = 7.0  4.5 transition a fast and slow
phase (Hfast+ Hslow = 43 ± 7 kcal mol-1) with a volume change associated with the
formation of hemiprotonated cytosine base pairs and concomitant collapse of the i-motif
oligonucleotide into a compact conformation were observed. TIMS-MS experiments
showed that gas-phase, kinetically trapped i-motif DNA intermediates produced by
nanoESI are preserved, with relative abundances depending on the solution pH conditions.
In particular, a folded i-motif DNA structure was observed in nanoESI-TIMS-MS for low
charge states in both positive and negative ion mode (e.g., z = +/- 3 to +/-5) at low pH
conditions. As solution pH increases, the cytosine deprotonation leads to the loss of
cytosine-cytosine+ (C•CH+) base pairing in the CCC strands and in those conditions we
observe partially unfolded i-motif DNA conformations in nanoESI-TIMS-MS for higher
charge states (e.g., z = - 6 to -9). Collisional induced activation prior TIMS-MS showed
the existence of multiple local free energy minima, associated with the i-motif DNA
unfolding at z = -6 charge state. For the first time, candidate gas-phase structures are
proposed based on mobility measurements of the i-motif DNA unfolding pathway.
Moreover, the inspection of partially unfolded i-motif DNA structures (z = -7 and z = -8
charge states) showed that the presence of inner cations may or may not induce
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conformational changes in the gas-phase. For example, incorporation of ammonium
adducts does not lead to major conformational changes while sodium adducts may lead to
the formation of sodium mediated bonds between two negatively charged sides inducing
the stabilization towards more compact structures in new local, free energy minima in the
gas-phase.
5.2 Introduction
Recent innovations in speed, accuracy, and sensitivity have established Mass
Spectrometry (MS) based methods as a key technology in the field of structural biology.1
Over the last two decades, native MS of intact biomolecules and biomolecular complexes
has permitted structural interrogation at biologically relevant conditions that are not
accessible by other methods.2-6 Most common gas-phase structural probes are based on (or
a combination of) tandem mass spectrometry (ergodic and non-ergodic), gas-phase
hydrogen-deuterium exchange, ion spectroscopy, and ion mobility spectrometry. In
particular, ion mobility spectrometry combined with mass spectrometry (IMS-MS), can be
a multifaceted approach that quickly provides insight into both the stable and intermediate
structures of biomolecules in the gas-phase. Traditional ion mobility spectrometry (IMS)
is based on the separation of ions under the influence of a weak electric field as they collide
with a bath gas of inert neutral molecules.7-9 The mobility provides information on the its
size and shape via the momentum transfer ion-neutral collision cross section (CCS).10
While this description holds true for most contemporary IMS analyzers (e.g., periodic
focusing DC ion guide
transient wave ion guide
24

11-12

, segmented quadrupole drift cell

17-18

13

, multistage IMS

14-16

,

, trapped ion mobility spectrometers19-23 and SLIM devices

), a common feature is that gas-phase studies take advantage of the desolvation process
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to effectively reduce sample complexity, permitting molecular characterization in the
absence of bulk solvent by studying gas-phase structures in kinetically trapped
intermediates. More recently, the combination of IMS-MS measurements with infrared
multi-photon dissociation (IRMPD) spectroscopy and infrared vibrational spectroscopy for
structural characterization of gas-phase molecular ions have shown the unique advantage
of gas-phase studies in order to better understand the intramolecular forces that define the
conformational space of biomolecules.

25-29

With the recent introduction of a new IMS

analyzer - Trapped Ion Mobility Spectrometer (TIMS)- the possibility to decouple the time
domain from the IMS separation allows for the study of kinetically trapped intermediates
of molecular ions in the gas-phase as a function of the desolvation time, temperature and
bath gas composition. TIMS’ mode of operation and its advantages over traditional IMS
are described in ref 19, 30-31. We have shown the use of TIMS for the study of isomerization
kinetics of small molecules32-34, peptides35-36, and proteins37-42, the influence of the
collision partner on the molecular structure43, and the factors that affect molecular-adduct
complex lifetime and stability during TIMS measurements44.
Here we report on a proton-sensitive DNA molecule based on the i-motif
conformation (i-motif DNA) that can reversibly fold in response to the solution pH
conditions.45-47 The i-motif DNA is a four-stranded DNA structure that forms due to
intramolecular noncanonical base pair interactions between a protonated and a neutral
cytosine residue (i.e., a CH+:C base pair) under slightly acidic conditions. At higher pH
values, the cytosines are neutral and the DNA strand adopts a random coil conformation.4849

Regardless of its impending role in oncogene regulation and anti-cancer therapies, 50-53

i-motif DNA has found multiple applications in the field of nanotechnology (e.g.,
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nanomotors, environmental sensors and pH switches). 54 Recent studies have shown that
nucleic acids can maintain their solution phase topology (e.g., duplexes, triplexes or Gquadruplexes55-57) when transferred to the gas phase via electrospray sources.58-59 A recent
work using ESI-TWIMS-MS and ESI-IRMPD-MS concluded that zwitterionic i-motif
DNA structures are preserved in negatively charged DNA ions.60 However, the detailed
structural features of the folded i-motif DNA and the variations in structure that occur in
response to changes in pH have received little attention.
In the present work, the conformational dynamics and folding/unfolding pathways
of i-motif DNA are investigated in solution and in the gas-phase. That is, i-motif DNA
was studied in solution for the pH range 4.0 – 9.0 at thermodynamic equilibrium using
circular dichroism (CD) and during the pH 7.0  4.5 transition using photoacoustic
calorimetry analysis (PAC), and in the gas-phase using nano electrospray ionization
trapped ion mobility spectrometry - mass spectrometry (nanoESI-TIMS-MS) with and
without collisional induced activation prior the TIMS-MS analysis. The TIMS-MS
measured ion-neutral collision cross sections are used to propose candidate structures based
on molecular dynamics (MD) simulations as a way to better understand the i-motif DNA
free energy landscape. In addition, the influence of inner cations on the stabilization of gasphase structures is discussed for partially unfolded i-motif DNA.
5.3 Experimental
5.3.1 Materials and reagents
A 21 base, cytosine-rich DNA sequence mimicking the telomeric repeat sequence
5’-[CCCTAA]3CCC-3’ (C198H256N72O121P20, MW 6200 Da) was obtained indistinctly from
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Eurofins Scientific (Huntsville, AL) and from Integrated DNA Technologies (Coralville,
IA) and used without further purification. Nitrobenzaldehyde (2-NBA) powder was
obtained from Sigma-Aldrich (St. Louis, MO). Solvents, hydrochloric acid, sodium
hydroxide, ammonium acetate, ammonium formate, and ammonium hydroxide salts
utilized in this study were analytical grade or better and purchased from Fisher Scientific
(Pittsburgh, PA). A Tuning Mix calibration standard (G24221A) was obtained from
Agilent Technologies (Santa Clara, CA) and used as received.
5.3.2 Circular Dichroism Analysis (CD)
Circular dichroism spectra were collected using a Jasco J-815 CD spectrometer
(Easton, MD) as a function of the solution pH. Spectra were collected from 1 mm quartz
cuvettes containing 30 µM i-motif DNA solubilized in deionized water at pH= 4.0, 5.0,
6.0, 7.0, 8.0 and 9.0. Solution pH was adjusted using hydrochloric acid (HCl) and sodium
hydroxide (NaOH).
5.3.3 Photo Acoustic Calorimetry Analysis (PAC)
A detailed description of PAC principles of operation and data analysis can be
found elsewhere

61

. Briefly,a solution of 30 µM i-motif DNA and 1 mM 2-NBA was

prepared in deionized water and stored in the dark to prevent unwanted photolysis. Solution
pH was adjusted using hydrochloric acid (HCl) and sodium hydroxide (NaOH). A 500 L
solution of i-motif DNA and 2-NBA solution was placed in a 1 cm x 0.5 cm quartz cuvette
(Starna Cells) and the cuvette was placed in a temperature-controlled sample holder with
magnetic stirring capability (TC 125, Quantum Northwest). The sample solution was
stirred during measurements to prevent accumulation of the photoproduct and a fresh
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aliquot was used for each temperature measurement; the PAC measurements were
performed over 16-26 oC temperature range. 2-NBA photo-dissociation and concomitant
proton release was triggered by a 355 nm laser pulse (500 µJ, Surelite I-10, Continuum).
Fe(III)tetraphenylsulfonato porphyrin (4-SP) solubilized in deionized water at pH 7.0 was
employed as a reference compound. The absorbance of the reference solution matched the
absorbance of the sample at the excitation wavelength of 355 nm. A piezoelectric
transducer (Panametrics RV103, 1 MHz) was adhered to the side of the cuvette and the
signal was amplified using an ultrasonic preamplifier (Panametrics 5662). The PAC traces
were recorded using a digital oscilloscope (Wave Surfer 42Xs, LeCroy) and were
deconvoluted using Sound Analysis software (Quantum Northwest, WA).
Acoustic transducers used in PAC measurements are sensitive to the amplitude of an
acoustic wave as well as to its temporal profile. For a two-step sequential decay process on
the time scale of the transducer resolution (∼50 ns to ∼10 μs), the individual contributions
of ΔV and ΔH for each kinetic process can be resolved. Changes in the phase and amplitude
of the PAC traces can then be correlated with structural changes in solution as a
consequence of the pH jump (reaction volume and enthalpy)61. For the initial process ( <
50 ns), the ratio of the sample and reference PAC signal amplitudes (1) is related to the
reaction volume (Vfast) and reaction enthalpy (Hfast) according to Eq. 1:

Ehv (1 -1)⁄𝛷 =∆𝑉𝑓𝑎𝑠𝑡 [

Cp ρ
β

] -∆𝐻𝑓𝑎𝑠𝑡

(1)

where Eh = 80.59 kcal mol-1,  is the quantum yield of the primary photo-reaction, and
Cpρ/β is a temperature-dependent parameter made up of the heat capacity (Cp), density (ρ)
and expansion coefficient (β) of the solvent.
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For slower processes (50 ns<  < 10 s), the ratio of the sample and reference PAC signal
amplitudes (2) is related to the reaction volume (Vslow) and enthalpy (Hslow) according
to Eq. 2:
𝐶𝑃 𝜚

Ehv (2 )⁄𝛷 = Δ𝑉𝑠𝑙𝑜𝑤 [

𝛽

] − Δ𝐻𝑠𝑙𝑜𝑤

(2)

5.3.4 Trapped Ion Mobility Spectrometry – Mass Spectrometry Analysis (TIMS-MS)
Details regarding the TIMS operation and specifics compared to traditional IMS
can be found elsewhere. 19-21, 62-63 Briefly, mobility separation in TIMS is based on holding
the ions stationary using an electric field against a moving gas. The separation in a TIMS
device can be described by the center of the mass frame using the same principles as in a
conventional IMS drift tube.10 Since mobility separation is related to the number of ionneutral collisions (or drift time in traditional drift tube cells), the mobility separation in a
TIMS device depends on the bath gas drift velocity, ion confinement and ion elution
parameters. The reduced mobility, K, of an ion in a TIMS cell is described by:
𝐾=

𝑣𝑔
𝐸

=

𝐴
(𝑉𝑒𝑙𝑢𝑡𝑖𝑜𝑛 − 𝑉𝑜𝑢𝑡 )

(3)

where vg and E are the velocity of the gas and the applied electric field across the TIMS
analyzer region. Velution is the voltage when the ions elute in the Vramp sweep and Vout is
the voltage applied at the end of the TIMS analyzer region.
A custom-built, pulled capillary nanoESI source was utilized for all the
experiments. Quartz glass capillaries (O.D.: 1.0 mm and I.D.: 0.70 mm) were pulled
utilizing a P-2000 micropipette laser puller (Sutter Instruments, Novato, CA) and loaded
with 10 L aliquot of the sample solution. Sample solutions consisted of 1 µM i-motif
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DNA in 10 mM ammonium acetate solution at three pH values (pH= 4.5, 7.0 and 9.0).
Solution pH was adjusted using ammonium formate and ammonium hydroxide salts. A
typical nanoESI source voltage of +/- 600-1200 V was applied between the pulled capillary
tips and the TIMS-MS instrument inlet. Ions were introduced via a stainless steel tube (1/16
x 0.020’’, IDEX Health Science, Oak Harbor, WA) held at room temperature into the TIMS
cell.
The TIMS cartridge is comprised of three regions: an entrance funnel, analyzer
tunnel (46 mm axial length), and exit funnel. A 880 kHz and 200 Vpp RF potential was
applied to each section creating a dipolar field in the funnel regions and a quadrupolar field
inside the tunnel. For collisional induced activation experiments prior the TIMS separation
(CIA-TIMS-MS), 2D-TIMS-MS spectra were collected as a function of the axial electric
field across the deflector plate and the end of the entrance funnel in 10V intervals of the
deflector voltage (Vdeflector = 0-200 V); the voltages across the entrance and exit of the
entrance funnel were adjusted relative to Vdeflector to guarantee an homogenous axial electric
field in all CIA measurements. TIMS separation was performed using nitrogen as a bath
gas at ca. 300 K, at a constant gas flow velocity defined by the pressure difference between
entrance funnel P1 = 1.1-4.3 mbar, and the exit funnel P2 = 0.6-3.0 mbar.33, 41
In TIMS operation, multiple geometric isomers/conformers are trapped
simultaneously at different E values resulting from a voltage gradient applied across the
TIMS tunnel. After thermalization, geometrical isomers/conformers are eluted by
decreasing the electric field in stepwise decrements (referred to as the “ramp”). Each
isomer/conformer eluting from the TIMS cell can be described by a characteristic voltage
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(i.e., Velution - Vout). Eluted ions are then mass analyzed and detected by a maXis impact QToF mass spectrometer (Bruker Daltonics Inc, Billerica , MA).
In a TIMS device, the total analysis time can be described as:
Total IMS time = ttrap + (Velution/Vramp)*tramp + ToF = to + (Velut/Vramp)*tramp

(4)

where, ttrap is the thermalization/trapping time, ToF is the time after the mobility separation,
and Vramp and tramp are the voltage range and time required to vary the electric field,
respectively. The elution voltage was experimentally determined by varying the ramp time
(tramp = 100, 200, 300, 400 and 500 ms) for a constant ramp voltage sweep. This procedure
also determines the time ions spend outside the separation region to (e.g., ion trapping and
time-of-flight). The TIMS cell was operated using a fill/trap/ramp/wait sequence of
10/10/50-500/50 ms. The TOF analyzer was operated at 10 kHz (m/z = 100-3500). The
data was summed over 100 analysis cycles yielding an analysis time of ~50 s for t ramp =
500 ms. Mobility calibration was performed using the Tuning Mix calibration standard
(G24221A, Agilent Technologies, Santa Clara, CA) in positive ion mode (e.g., m/z = 322,
K0 = 1.376 cm2 V-1 s-1 and m/z = 622, K0 = 1.013 cm2 V-1 s-1).21 The TIMS operation was
controlled using in-house software, written in National Instruments Lab VIEW, and
synchronized with the maXis Impact Q-ToF acquisition program.19-20
Reduced mobility values (K0) were correlated with CCS (Ω) using the equation:

18 1/ 2

16

z
k BT 1/ 2

 1
1 



 m I mb 

1/ 2

1 1
K0 N *

(5)
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where z is the charge of the ion, k is the Boltzmann constant, N* is the number density
B

and m and m refer to the masses of the ion and bath gas, respectively.10 All resolving
I

b

power (R) values reported herein were determined from Gaussian peak fits of the features
in the TIMS distributions (R = Ω/ΔΩ) using OriginPro (version 8.0). The FWHM of the
mobility band was used to calculate the ΔΩ.
5.4 Theoretical
Candidate structures search and assignment from TIMS-MS data was performed
based on the workflow described in reference64. Briefly, an initial guess was performed
based on the folded i-motif DNA 1ELN structure from protein data bank
dynamic

simulations

were

performed

with

65

. Molecular
NAMD

(http://www.ks.uiuc.edu/Research/namd/)66 using CHARMM36 force field67, which
shows significant improvements over previous force-fields for simulating the nucleic
acids.68 CHARMM-GUI69 web-server was used to initialize the MD simulations. The imotif DNA was solvated in a 53 Å cubic box with TIP3P water model and the system was
neutralized by adding eight Mg2+ and two Cl- ions.
A 10,000-step energy minimization was performed using the conjugate gradient
and line search algorithm, followed by a 100-ps NVT equilibration at 300 K and 1 atm
pressure with periodic boundary conditions. The particle mesh Ewald method70 was used
to treat the long-range interactions with a 12 Å nonbonded cutoff. The RATTLE algorithm
was used to constrain protein bonds involving hydrogen, and SETTLE was used to
maintain water geometry. A 400-ns NPT simulation was performed with a 2 fs integration
time step at 300 K and 1 atm pressure. A total of 18,000 structures were submitted to the
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CCS calculation and clustered based on RMSD using our custom-built R-code software64.
A minimum of five distinct center of mass structures (CM) were selected per experimental
IMS band observed from the cluster analysis based on energy minimization and CCS
calculation as a function of the charge state [CM, CCS]charge. The MD force field energy
minimization did not properly describe the hemiprotonated cytosine interactions leading to
mostly [CM, CCS]charge of unfolded i-motif DNA. To overcome this limitation, the final
set of candidate structures also included structures generated based on the trends observed
during the i-motif DNA unfolding 400-ns trajectory and the previously reported i-motif
DNA folded structure65. CCSs were calculated using the IMoS (v1.04b)71-73 and PSA74
packages with nitrogen as a bath gas at ca. 300K. In the IMoS calculations, 100 total
rotations were performed using the trajectory method with a Maxwell distribution.
Molecular visualization was performed using Visual Molecular Dynamics software.75
5.5 Results and Discussion
This work utilizes solution and gas-phase experiments for the study of equilibrium
and kinetic intermediates of the i-motif DNA system. Specifically, CD and TIMS-MS
provide information of i-motif DNA structures as a function of solution pH, whereas PAC
and CIA-TIMS-MS interrogate kinetic intermediates during the folding and unfolding
pathways, respectively. These complementary techniques allow different conformational
states to be unveiled and provide a more detailed interpretation of the folding pathway and
unfolding intermediates in the presence and absence of bulk solvent, respectively. The
focus of this paper is towards a better description of the i-motif DNA free energy landscape.
At thermodynamic equilibrium in solution, the transition from basic to acidic pH
solution conditions of the i-motif DNA can be characterized by an increase of the 287 nm
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band and the concomitant decrease of the 272 nm band in the CD signal (see Figure 5.1),
being more significant in the pH = 4.0 - 7.0 range. The observation of two isosbestic points
at 245 nm and 276 nm suggests a two state folding mechanism (FU) for the i-motif DNA
as a function of the solution pH. 76 It should be noted that a two state folding mechanism

Figure 5.1. Circular dichroism spectra of i-motif DNA (30 µM in deionized water) as a
function of the solution pH =4.0 – 9.0 at 20 °C. Notice that no changes in the spectra are
observed in the pH = 7.0 – 9.0 range.
does not limit the number of conformations to two; that is, multiple conformations may
exist at equilibrium in the folded and unfolded states (e.g., the CD signal at pH = 6 contains
mixed states).
Complementary gas-phase analysis was performed as a function of the solution pH
and time after desolvation using nanoESI-TIMS-MS. This gas-phase analysis takes
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advantage of the desolvation process to effectively reduce sample complexity and permit
molecular characterization in the absence of bulk solvent. The rationale is to kinetically
trap gas-phase structural populations (or ensemble) in local, free energy minima close to
the initial, thermodynamic equilibrated solution-phase structural populations (or
ensemble). Previous works have shown the presence of solution memory effects by looking
at the changes on the IMS profile as a function of the desolvation time.62, 77-80.
The nanoESI-TIMS-MS analysis of i-motif DNA resulted in the observation of
molecular ions in positive and negative ion mode (see Figure 5.2). In positive mode, a
narrow charge state distribution (+3 - +5) is observed with no major variation as the
solution pH. In negative mode, a broad distribution of charge states (-3 - -9) is observed
with relative abundances changing with the solution pH. We interpret the changes in the
MS relative abundances in negative mode with the solution pH increase as a consequence
of the loosening of the C•CH+ base pairing that stabilizes the folded i-motif conformation
leading to more deprotonation sites in the partially unfolded i-motif DNA structures. In the
case of positive mode, as the pH decreases the cytocines become protonated leading to the
i-motif folding, limiting the number of accessible protonation sites. Notice that this trend
is unique for the i-motif DNA compare to other reported studies of biological molecules
(e.g., some peptides and proteins) where denaturing at low pH conditions leads to the
observation of higher charge states and native conditions (pH = 6 - 8) show a narrow low
charge state distribution.77,

81-89

That is, the stabilization of the i-motif DNA with the

reduction of the solution pH results in the observation of a narrow charge state distribution
in positive mode. Despite the changes in the MS relative abundances of the charge states
with the solution pH, closer inspection of the mobility profiles did not show any
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dependence on the solution condition or the time after desolvation (details for the TIMS
profiles as a function of the time after desolvation overt the 50-500 ms range can be found
in the supporting information). Moreover, major changes in the CCS values were observed
as a function of the i-motif DNA charge state. Low charge states (e.g., +3 to +5 and -3 to -

Figure 5.2. Typical positive (red) and negative (blue) mass spectra (top) and mobility
profiles for i-motif DNA as a function of the solution pH (4.0 – 9.0) using low energy
injection nanoESI-TIMS-MS. Notice the change in the charge distribution as a function of
the solution pH. Changes in individual charge states mobility profiles were not observed
as a function of the solution pH conditions.
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5) can be described by a single, broad mobility band60, with slightly increasing CCS as a
function of the charge state. Notice that the increase of CCS with the charge state is an
expected trend and does not necessarily reflect conformational changes for z = +3 to +5
and -3 to -5. However, a major transition is observed at z = -6, with the observation of
partially unfolded i-motif DNA structures in the z = -6 to -9 charge states. The CCS trend
observed in negative mode as a function of the charge state is in good agreement with
previous ESI-TWIMS-MS experiments90-93; however, this study takes advantage of
TIMS’s higher mobility resolution to resolve a higher number of IMS bands and to report
accurate ion-neutral collision cross sections.
Solution phase analysis of i-motif DNA transition (UF) during the pH jump from
7.0 to 4.5 was performed by PAC and permitted the interrogation of the folding process
(kinetic intermediates) on the nanosecond to microsecond timescale. The photolysis of 2NBA leads to a prompt pH decrease (pH ~ 2.5 units) due to the 2-NBA photo-conversion
to nitroso-benzoate (see details in Scheme 1). For the 2-NBA photo-dissociation, reaction
enthalpy ΔH = -29.2 ± 6.6 kcal mol-1 and volume change ΔV = -5.1 ± 1.6 mL mol-1 were
observed in agreement with previously published data.94 In the presence of i-motif DNA,
the fast increase in the proton concentration (pH 7.0  4.5) initiates the folding of i- motif
DNA . Acoustic traces for the photolysis of 2-NBA in the presence of i-motif DNA show
a phase shift and amplitude change with respect with the reference acoustic traces,
indicative of the presence of two processes, one occurring within the first 50 ns (fast phase,
1), and a temperature-dependent process with a time constant of 140 ns (slow phase, 2)
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at 20 °C (see Figure 5.3). After subtraction of V/H determined for 2-NBA photolysis in
the absence of i-motif DNA, the reaction parameters for the fast and slow processes are

Figure 5.3. Plot of the fast (ϕ1) and slow (ϕ2) phases as a function of Cpρ/β in the 16 – 26
°C temperature range. In the inset, PAC traces for 2-NBA photo-dissociation in the
presence of i-motif DNA sample (blue) and 4SP reference compound (red) at 16 °C.
ΔHfast= 8.5 ± 7.0 kcal mol-1 and ΔVfast= 10.4 ± 1.6 mL mol-1 and ΔHslow = -51.5 ± 4.8 kcal
mol-1 and ΔVslow = -6.6 ± 0.9 mL mol-1, respectively.
The fast process observed in PAC measurements ( < 50 ns) can be attributed i) to
the photo-dissociation of 2-NBA and concomitant release of protons (with a time constant
of ~20 ns95) and ii) to cytosine residue protonation (assuming the rate of pyridine
protonation in solution ~ tens of picoseconds)96. During the pH jump (pH 7.0  4.5),
approximately six cytosine residues (pKa = 4.58)97 will be protonated with an enthalpy
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change of -30 kcal mol-1 (assuming a H = -5.0 kcal mol-1 per cytosine residue98). Since a
positive enthalpy change of 8.5 ± 7.0 kcal mol-1 was determined for the fast process, an
additional endothermic process with H ~ 38.5 ± 7.0 kcal mol-1 must occur within 50 ns
of 2-NBA dissociation. This endothermic enthalpy change can be attributed to the decrease
in the solvent electrostriction due to reduction of the overall DNA charge.
The reaction parameters determined for the slow phase are consistent with i-motif
DNA nucleation. Nucleation of the intramolecular i-motif DNA structure requires the
formation of at least one hemiprotonated cytosine base pair, an interaction that consists of
three hydrogen bonds between one protonated and one neutral cytosine residue within an
oligonucleotide. Though empirical measurements of the enthalpy of this specific basepairing interaction are not available, the enthalpy of inter base pair hydrogen bond
formation was determined for the canonical GC Watson-Crick base to be -8.0 kcal mol-1.99
Within the intramolecular i-motif DNA with six protonated cytosines, up to six cytosinecytosine base-pairing interactions can be formed for a contribution of -48 kcal mol-1 to the
observed enthalpy for the folding process. In addition, formation of the i-motif structure
results in stacking of the cytosine bases, an interaction with an enthalpy of -5.0 kcal mol-1
per base pair stack.100 Formation of the folded i-motif DNA structure results in the
formation of 5 base pair stacking interactions with a contribution of -25 kcal mol-1 to the
observed enthalpy. Therefore, formation of the fully folded i-motif DNA should provide
ΔHobs= -73 kcal mol-1 or ~-12 kcal mol-1 per hemiprotonated cytosine base pair. The
enthalpy change determined here for the slow process ΔH slow = -51.5 ± 4.8 kcal mol-1
reflects the formation of approximately 4.5 hemiprotonated cytosine base pairs. The
observed volume change (ΔVslow = -6.6 ± 0.9 mL mol-1) is consistent with the formation of
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hemiprotonated cytosine base pairs and concomitant collapse of the oligonucleotide into a
more compact conformation with a smaller volume as observed previously using small
angle X-ray scattering.101 The overall reaction enthalpy change (Hfast+ Hslow = 43 ± 7
kcal mol-1) is similar to that previously determined by NMR for the intramolecular folding
of a similar cytosine-rich strand (5’-[TCC]4-3’) with fewer potential base pairing
interactions (-43 kcal mol-1)102 and for the reverse process of i-motif DNA unfolding using
differential scanning calorimetry (66 kcal mol-1).100 That is, the PAC experiments suggest
that during the pH 7.0  4.5 transition, the i-motif DNA folds in two consecutive steps: i)
protonation of cytosines and ii) nucleation and stacking towards the i-motif DNA structure.
In addition, the time scale of the PAC measurement (50ns - 10s) does not probe
rearrangements occurring in timescales larger than a few microseconds; that is, these
results suggest that due to the nature of the i-motif folding (C•CH+ pairing and stacking)
other kinetic intermediates are likely to be populated in the millisecond timescale. Notice
that PAC measurements access kinetic intermediates, not accessible during CD
measurements performed at thermodynamic equilibrium. That is, CD and PAC
measurements provide complementary information on the solution conditions and
intermediate transitions characteristic of the DNA i-motif folding, respectively.
In the gas-phase, collisional induced activation prior to the TIMS-MS analysis was
used to access kinetic intermediates not accessible during the solution conditions (e.g., pH
variation) and desolvation process. Previous reports have shown the advantage of this
methodology for the study of biomolecules and biomolecular complexes using in-source
activation and collision induced unfolding (CIU) prior to IMS-MS analysis.14, 80, 103-107
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Notice that in the case of CIA-TIMS-MS, the extent of activation is limited by the local
pressure and the electric field range accessible in the TIMS cartridge (i.e., there is a higher
limit in the electric field to avoid breakdown). We prefer to called it CIA instead of CIU
since the cooling process that occurs during the TIMS measurement can also lead to
refolding into a more compact structure not accessible during the molecular ion formation.
In the case of i-motif DNA, the intramolecular forces (C•CH+ pairing) that define the folded
states are overcome for the populations observed at z = -6. Our interpretation of the broad,
bimodal mobility distribution is the existence of a transition point towards multiple local
free energy minima: from folded to unfolded i-motif DNA (see Figure 5.2). Notice that the
observation of a broad distribution can be justify with the co-existence of multiple minima
reflecting the noncanonical hemiprotonated cytosine base pairing mechanism. A more
detailed investigation using collisional induced activation of the i-motif-DNA prior to the
TIMS mobility separation confirmed that most of the unfolding of the i-motif DNA
structure occurs for z = - 6 (see Figure 5.4). The z = -5 charge state also showed a movement
toward unfolding, with the population of a new IMS band at larger CCS value. This result
suggests that the conformational interconversion energy barriers for the z= -5 and z= -6
charge state structure can be easily overcome with collisional activation prior to the
mobility separation and that the existence of multiple, local free energy minima can be
visualized by the broad IMS profiles observed at z = -5, -6 and -7. The broad distribution
of z = -5, -6 and -7 IMS bands does not allow to make a discrete annotation on the number
of conformational states (at least with TIMS measurements performed at room
temperature). Changes in the mobility profiles for the other charge states upon activation
were not observed. The bimodal distribution and changes in the mobility profile upon
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Figure 5.4. Typical CIA-TIMS-MS profiles of i-motif DNA as a function of the deflector
voltage Vdeflector 60V (top) and 140V (bottom). Notice the change in the mobility
distribution for the z= −5 and z= −6 as a function of the molecular ion activation prior the
TIMS-MS analysis.

activation using CIA-TIMS-MS agree with previous reports of i-motif DNA activation in
the entrance cone of a TWIMS-MS.60
The search for candidate structures resulted in the generation of an average
structure for the major mobility trends observed in Figures 5.2 and 5.4. Inspection of the
candidate structures suggest that the folded state observed for the low charge states ( +3 to
+5 and -3 to -5) shares the same main interactions: stabilization via cytosine-cytosine+
(C•CH+) and adenosine – thymidine (A-T) base pairing at weakly acidic pH values (see
Figure 5.5). The most compact structure was observed for z = +3, with only small
differences in the distances between the base pairs (vertical direction in Figure 5.5) as the
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charge state increases from +3 to +5 and from -3 to -5. That is, major conformational
differences were not observed between candidate structures proposed for positive and
negative ions (e.g., +3 to +5 and -3 to -5); our interpretation is that differences in the CCS
values are mostly due to the charge state and the internal base pairing stacking. Inspection
of the candidate structures at the z = -6 charge state suggests that the broad, bimodal CCS
distribution is probably due to cytosine neutralization. That is, the i-motif DNA structure
begins transformation towards an overall larger CCS trend where a semi-open hairpin
structure with a relaxed 5’ end first appears. Specifically, this larger CCS trend has the
common loss of the cytosine-cytosine+ (C•CH+) interactions in one of the CCC strands for
the extended z = -6 and the z = -7 charge states, with a further loss of the second CCC
strand interactions for the z = -8 and z = -9 charge states. The folding pattern proposed as
a function of the charge state is in good agreement with the previous studies suggesting
that the hairpin-like structures are the most stable conformations during the i-motif DNA
deprotonation.108 While full unfolding of the i-motif DNA is never reached during CIATIMS-MS, the CCS profiles and candidate structures are in good agreement with
previously reported DNA structural models101. Notice that the proposed candidate
structures were generated based on a 400ns MD trajectory and the previously reported imotif DNA folded structure65. The MD simulation described the unfolding of the i-motif
DNA using a starting structure with deprotonated cytosines. Other MD attempts to simulate
the folding of the i-motif- DNA using protonated cytosines were not successful; our
interpretation is that further development of the force fields are required to better simulate
DNA interactions and base pair stacking109. Nevertheless, for the first time candidate
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Figure 5.5. Candidate structures proposed for the i-motif DNA mobility bands observed.
Main intramolecular interactions are denoted. CCSs of the candidate structures are reported
in Table 1.
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Table 5.1. Experimental and theoretical collision cross sections for i-motif DNA bands
observed in positive and negative ion mode in nanoESI-TIMS-MS and proposed candidate
structures, respectively.
Experimental

Theoretical

CCSN2 (Å2)

CCSN2 (Å2)

0.748

800

811

+4

0.944

846

846

+5

1.089

922

926

-3

0.729

821

832

-4

0.931

863

865

-5

1.096

917

903

1.178

1023 (A)

1021

1.013

1190 (B)

1166

1.267

1111 (A)

-

1.140

1234 (B)

-

1.071

1314 (C)

-

1.034

1360 (D)

1378

1.204

1335 (A)

-

1.181

1362 (B)

-

1.153

1394 (C)

-

1.119

1436 (D)

1445

1.100

1462 (E)

1455

1.085

1482 (F)

1492

1.168

1548

1546

z

K0 (cm2 V-1 s -1)

+3

-6

-7

-8

-9
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structures are proposed for kinetically trapped intermediates of the i-motif DNA folding
which allows for a better mechanistic understanding of the free energy landscape.
In addition to structural changes of the i-motif DNA as a consequence of the
noncanonical hemiprotonated cytosine base pairing, the presence of inner cations may also
induce preference for alternative kinetically trapped conformations in the gas-phase. For
example, closer inspection of the higher charge state distributions showed the presence of
multiple sodium and ammonium adducts for z= -7 and z= -8 (see Figure 5.6). These adducts
can be attached to the i-motif-DNA structure and result in: i) no conformational changes
(no shift in the IMS profile), or ii) can stabilize the i-motif DNA structure in other folding
states (shift in the IMS profile). Inspection of the mobility profiles in the presence of
adducts shows that while ammonium incorporation does not drive major changes in the
mobility profile, sodium adducts act as a positively charge contact point between
negatively charged strands (most likely phosphate groups) of the i-motif-DNA resulting in
more compact structures. Since both z = -7 and z = -8 are partially unfolded, the appearance
of new mobility bands suggests that sodium ions acts as bridges between the CCC strands,
stabilizing the complex in other local free energy minima. That is, the introduction of the
sodium cation may allow CCC strands to come together and create a sodium mediated
bond, forming a tighter structure (smaller CCS). The interaction of inner cations on DNA
folding will be further investigated utilizing this methodology in a following publication.
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Figure 5.6. Typical mass spectra and mobility profiles for different i-motif DNA molecular
ions observed at the z= −7 and z= −8 charge state. Notice the change in the mobility
distribution in the presence of the ammonium and sodium adducts.
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5.6 Conclusions
Folding dynamics of i-motif DNA in solution and in the gas-phase were studied
using circular dichroism, photoacoustic calorimetry, trapped ion mobility spectrometry and
molecular dynamics. Solution studies using CD showed a two state folding mechanism
(FU) for the i-motif DNA as a function of the solution pH = 4.0 – 9.0 at thermodynamic
equilibrium. The photolysis of 2-NBA in the presence of i-motif DNA displayed a phase
shift indicating the presence of two processes, one occurring within 50 ns (fast phase) of
the laser pulse and a temperature-dependent process with a time constant of 140 ns (slow
phase) at 20 °C with an overall reaction enthalpy change (Hfast+ Hslow = 43 ± 7 kcal mol1

). The observed volume change during PAC experiments suggested the formation of

hemiprotonated cytosine base pairs and concomitant collapse of the i-motif oligonucleotide
into a more compact conformation with a smaller volume during the pH 7.0  4.5
transition at kinetic equilibrium. The nanoESI-TIMS-MS experiments showed that during
the nanoESI process the i-motif DNA structures are kinetically trapped in intermediates
that retain the main conformational motifs (C•CH+ base pairing) for low charge states. In
particular, an i-motif DNA structure is observed for the low charge states in both positive
and negative ion mode (e.g., +/- 3 to +/-5) at low pH conditions. With the pH increase the
cytosines become neutralized leading to the loss of the cytosine-cytosine+ (C•CH+) base
pairing in the CCC stretches and a charge state distribution increase to higher charges is
observed in negative mode. The loss of the cytosine-cytosine+ (C•CH+) base pairing in the
CCC stretches results in the observation of partially unfolded i-motif DNA conformations.
CIA-TIMS-MS experiments showed a broad IMS distribution for z = -5, -6 and -7 and the
existence of multiple, local free energy minima different from those obtained by varying
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the pH solution conditions. Molecular dynamics simulations were used to sample the gasphase conformations and to generate candidate structures during i-motif DNA unfolding.
For the first time, an unfolding mechanism is supported by average candidate structures
from mobility measurements as a function of the i-motif DNA unfolding pathway and the
main intramolecular interactions that stabilized the process are described. Inspection of
partially unfolded i-motif DNA structures, for intermediate charge states in negative ion
mode, showed that sodium, but not ammonium, induces changes in the population of gasphase kinetic intermediates.
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CHAPTER 6: AT-HOOK PEPTIDES BIND THE MAJOR AND MINOR
GROOVE OF AT-RICH DNA
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6.1 Abstract
The mammalian high mobility group A2 protein (HMGA2) houses three motifs that
preferentially bind short stretches of AT-rich DNA regions. These DNA binding domains,
known as “AT-hooks”, are traditionally characterized as being unstructured. Upon binding
to substrates, they form ordered assemblies. It is this disordered-to-ordered transition that
has implicated HMGA2 as a protein actively involved in many biological processes, with
abnormal HMGA expression linked to a variety of health problems including diabetes,
obesity and oncogenesis. In the current work, gas-phase ion mobility spectrometry -mass
spectrometry (IMS-MS) analysis was used to observe the conformations populated by each
AT-hook peptide (ATHP) and DNA complex. The resulting mobility distributions showed
that the three ATHPs bind DNA to form a single “key-locked” conformational ensemble.
Together with molecular models, complex formation was determined to occur between
ATHP and a pre-folded AT-rich DNA hairpin substrate. Interestingly, candidate structural
analysis also revealed the ability of the peptides to bind the minor and major grooves of
the DNA. Employing additional gas-phase IMS-MS studies and solution isothermal
titration calorimetry (ITC) we observe for the first time results of a 2:1 stoichiometry of
ATHP:DNA.
6.2 Introduction
HMGA2 is a 12 kDa member of the non-histone chromosomal HMG protein
family. Three DNA binding motifs present in the protein, known as “AT-hook” domains,
exhibit specificity for binding to AT-rich DNA sequences.1 A conserved set of tripeptide
core residues (-Arg-Gly-Arg-), primarily surrounded by basic amino acids, are responsible
for this specificity.2 Variants of HMGA2 have been linked to human height3-5 and levels
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of expression are associated with obesity,6-7 diabetes,8 human intelligence,9 stem cell
youth10 and oncogenesis.11-14 Such involvement in significant biological processes,
specifically the direct binding to transcription factors, has implicated HMGA proteins as
potential therapeutic drug targets.15-17
However, HMGA2 provides an additional level of interest because of its
classification as an intrinsically disordered protein18-19. The presence of ‘unstructured’
biomolecules in eukaryotic proteins comprises a surprisingly large number, with as many
as 25% predicted to be disordered.20 The important role these proteins have in maintaining
cellular function most likely comes from their ability to conform to multiple binding
partners. For example, in the absence of an AT-rich DNA substrate, the high mobility group
AT-hook 2 (HMGA2) is highly flexible and adopts random coils.18 However, it is the
conformational changes upon DNA binding, and subsequent transition from unstructured
to structured, that allows HMGA2 to be involved in several fundamental biological
processes, including DNA replication, translation, recombination and gene regulation.1, 9,
11, 21-22

Through the use of various techniques, structural elucidation of protein-DNA
complexes have grown substantially, as knowledge of complex interfaces have been crucial
to the development of new therapeutic targets and better disease prevention strategies,23
yet the specifics still remain unclear regarding the conformational changes required by the
protein and DNA to form complexes.24 Previous studies, using NMR18 and
crystallography,15 provide insight into the intermolecular interactions that support the
binding of the AT-hook motifs with DNA. The consensus is that the tripeptide core motif
is positioned deep into the minor groove forming hydrogen bond contacts with the bases,
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along with a variety of electrostatic and van der waals interactions. More recent
experimental analysis, involving ATHP complexes, show the ability for RNA binding via
an extended peptide motif25 and increase in DNA binding affinity upon conjugation to a
minor groove binder.26 Unfortunately, information comparing the structural differences
between the three AT-hook domains and their capacity to form DNA complexes is limited,
confined only to select solution-phase and x-ray diffraction studies.
However, the combination of solution and gas-phase techniques, has proven to be
very versatile and powerful in terms of structural analysis of biomolecules. In particular,
intermediate states can be easily probed by IMS-MS technology, which when
complemented by solution measurements provides a definitive picture of complex
structural isomers, binding affinity and molecular stability.
In the present work, we report on the conformational changes and ATHP-DNA
complex formation of the three AT-hook peptides of HMGA2 in solution and in the gasphase using DNA UV melting studies, florescence spectroscopy, isothermal titration
calorimetry (ITC), IMS-MS and molecular modeling. The main motifs that define the
conformational space of the HMGA2 domains (ATHP 1-3) and the DNA-ATHP complex
formation are described. Although prior studies note only minor groove ATHP interactions,
here we present solution- and gas-phase experimental and theoretical evidence of both
ATHP major and minor groove binding capabilities.
6.3 Experimental
6.3.1 Materials and reagents
An

AT-rich

DNA

oligomer,

GGATATTGCCCCCGCAATATCC

denoted

(C212H270N79O130P21,
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as
MW

FL876,

sequence

6655.1561)

was

purchased from Eurofins Scientific (Luxembourg, Luxembourg) and used as received. This
22 nucleotide DNA hairpin contains a 9 base pair stem including a 5 base pair AT DNA in
the middle of the stem. AT-hook peptides 1 (Lys-Arg-Gly-Arg-Gly-Arg-Pro-Arg-Lys), 2
(Pro-Lys-Arg-Pro-Arg-Gly-Arg-Pro-Lys) and 3 (Lys-Arg-Pro-Arg-Gly-Arg-Pro-Arg-LysTrp) were purchased from Advanced ChemTech Inc. (Louisville, KY) and used as
received. Solvents, BPE buffer, and ammonium acetate salts utilized in this study were
analytical grade or better and purchased from Fisher Scientific (Pittsburgh, PA). A Tuning
Mix calibration standard (G24221A) was obtained from Agilent Technologies (Santa
Clara, CA) and used as received.
6.3.2 DNA UV melting studies
DNA UV melting curves were determined using a Cary 100 UV-Vis
spectrophotometer (Agilent Technologies, Santa Clara, CA) equipped with a
thermoelectric temperature-controller. DNA oligomer FL876 in 1×BPE buffer was used
for melting studies. DNA-peptide samples were prepared to a final concentration of 2 µM
by directly mixing at a molar ratio of 1:10 FL876 DNA with each ATHP peptide, followed
by incubation for 60 min at room temperature to ensure equilibration. Samples were
typically heated in the 20-100 °C range at a rate of 1 °C min-1, while continuously
monitoring the absorbance at 260 nm. Primary data were transferred to the graphic program
Origin (MicroCal, Inc., Northampton, MA) for plotting and analysis.
6.3.3 Fluorescence Measurements
Fluorescence spectra of DNA-ATHP 3 were acquired using a Jobin Yvin Horiba
FluoroMax-3 with excitation wavelength of 355 nm. In the titration experiments, 99 nM
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FL876 and 50 nM Hoechst stain in 1×BPE was titrated by increasing concentrations of
ATHP 3. The fluorescence spectra were recorded from 400 to 550 nm.
6.3.4 Isothermal Titration Calorimetry (ITC)
ITC experiments were performed using a VP-ITC titration calorimeter (MicroCal,
Inc., Northampton, MA) interfaced to a personal computer. Origin 7.0 was used for data
acquisition and processing. A typical ITC experiment was set up so that 10 uL of ATHP
ligand, i.e. 300 uM ATHP1, 300 uM ATHP2 and 150 uM ATHP3, was injected every 120
seconds for 30 injections into a 5 uM DNA sample (1 x BPE buffer) in the sample cell.
6.3.5 Trapped Ion Mobility Spectrometry – Mass Spectrometry Analysis (TIMS-MS)
Details regarding the TIMS operation and specifics compared to traditional IMS
can be found elsewhere. 27-31 Briefly, mobility separation in TIMS is based on holding the
ions stationary against a moving gas using an electric field. The separation in a TIMS
device can be described in the center of the mass reference frame using the same principles
as in a conventional IMS drift tube.32 Since mobility separation is related to the number of
ion-neutral collisions (or drift time in traditional drift tube cells), the mobility separation
in a TIMS device depends on the bath gas drift velocity, ion confinement and ion elution
parameters. The reduced mobility, K, of an ion in a TIMS cell is described by:
𝐾=

𝑉𝑔
𝐴
=
𝐸
(𝑉𝑒𝑙𝑢𝑡𝑖𝑜𝑛 − 𝑉𝑜𝑢𝑡 )

where vg and E are the velocity of the gas and the applied electric field across the TIMS
analyzer region. Velution is the voltage when the ions elute in the Vramp sweep and Vout is
the voltage applied at the end of the TIMS analyzer region.
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A custom-built, pulled capillary nanoESI source was utilized for all the
experiments. Quartz glass capillaries (O.D.: 1.0 mm and I.D.: 0.70 mm) were pulled
utilizing a P-2000 micropipette laser puller (Sutter Instruments, Novato, CA) and loaded
with 10 L aliquot of the sample solution. Sample solutions consisted of 1-10 µM ATHP
or DNA in 10 mM ammonium acetate solution at physiological pH (pH = 6.7). For the
observation of the DNA-ATHP complexes, a 1:1 and 1:2 ratio of 5 µM concentration of
the DNA and AT-hook peptide (1, 2 or 3) was prepared in 10mM ammonium acetate
immediately prior infusion. A typical nanoESI source voltage of +/- 600-1200 V was
applied between the pulled capillary tips and the TIMS-MS instrument inlet. Ions were
introduced via a stainless steel tube (1/16 x 0.020’’, IDEX Health Science, Oak Harbor,
WA) held at room temperature into the TIMS cell.
Mobility calibration was performed using the Tuning Mix calibration standard
(G24221A, Agilent Technologies, Santa Clara, CA) in positive ion mode (e.g., m/z = 322,
K0 = 1.376 cm2 V-1 s-1 and m/z = 622, K0 = 1.013 cm2 V-1 s-1).31 The TIMS operation was
controlled using in-house software, written in National Instruments Lab VIEW, and
synchronized with the maXis Impact Q-ToF acquisition program.27-28
Reduced mobility values (K0) were correlated with CCS (Ω) using the equation:
(18𝜋)1/2
𝑧
1
1 1/2 1 1
Ω=
[ +
]
16 (𝑘𝐵 𝑇)1/2 𝑚𝑖 𝑚𝑏
𝐾0 𝑁 ∗
where z is the charge of the ion, kB is the Boltzmann constant, N* is the number density
and mI and mb refer to the masses of the ion and bath gas, respectively.32
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3.3.6 Theoretical Calculations
Candidate structures were proposed for the mobility bands observed in the TIMS-MS
experiments. The protein data bank (PDB) entry 2EZD was used as a template for the
peptide-DNA candidate structures. First, a 2-dimensional DNA hairpin structure was
obtained for the DNA sequence using mFold server33. Based on this structure, a 3dimensional hairpin structure was then created by merging PDBs 2EZD (for the stem) with
2K71 (for the tetra-nucleotide loop) followed by mutations with appropriate bases in order
Scheme 1. Preparation of PDB template for modeling of DNA.
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to achieve the desired structure (see Scheme 1). The modeled DNA hairpin structure was
optimized by energy minimization with CHARMM36 force field34 using NAMD
Molecular Dynamics package35. Molecular docking was performed using AutoDock vina36
to generate the DNA-ATHP complexes.. Theoretical CCS were calculated using the IMoS
(v1.04b)

37-39

and PSA40 packages with nitrogen as a bath gas at ca. 300K. In the IMoS

calculations, 100 total rotations were performed using the trajectory method with a
Maxwell distribution. Molecular visualization was performed using Visual Molecular
Dynamics software.41
6.4 Results and Discussion
Gas phase analysis of ATHP 1, 2 or 3 in complex with the FL876 oligonucleotide
produced [M+4H]+4 and [M+5H]+5 ions (Figure 6.1). MS analysis of equal molar sample
ratios shows that a 1:1 peptide with DNA stoichiometry is produced, accompanied by each
species in free form (Appendix 6.1, left panel). Inspection of the corresponding IM
complex profiles show a single mobility band recorded for each charge state. Structures
were proposed based off these initial findings and suggest the likelihood of the ATHPs
attaching to either the major or minor grooves of the DNA hairpin. This contrast from
current reports in literature (e.g., ATHPs are specific minor groove binding molecules)
subsequently motivated a series of experiments to evaluate the binding specificity of each
motif.
We proceeded by using Hoescht 33528, a fluorescent dye known as a minor groove
binding (MGB) compound that is highly specific to AT-rich DNA substrates. By blocking
the minor groove, ATHP attachment was restricted to the major groove of FL876 so that
the presence or absence of binding could be determined. Although displacement of the
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Hoescht 33258 compound in the minor groove by ATHPs is possible, we hypothesized that
the majority of ATHPs would attach to the major groove, if applicable, leaving the minor
groove occupied by the dye. In fact, experimental IMS-MS results confirmed that all three
ATHPs have the ability to bind to the FL876 : Hoescht complex, forming 1 : 1: 1 molecular
assemblies (Figure 6.2). Additional theoretical studies were performed with the MGB
compound and complement the initial findings of ATHP major groove binding capabilities.
Comparison between the relative abundance of the complexes in the mass spectra showed
that ATHP : DNA is significantly favored over the ATHP : DNA : MGB state (data not
shown), signifying that ATHP bound to the minor groove is preferred.
Upon confirmation of the interaction between ATHP and the major groove of
FL876, the peptide concentration was increased two-fold, with respect to DNA, to assess
the possibility of two peptides with one DNA (bound to the major and minor grooves). An
increase in ATHP : DNA binding to 2:1 was observed at [M+5H]+5 charge state (Figure
6.3).
The experimental IMS-MS results suggest that the small difference in CCS
distributions (<200 Å2) between the 1:1 and 2:1 complexes could be an indication that the
peptide(s) is mostly concealed within the DNA hairpin structure. The proposed structures
provide an illustration of the complex, showing that the size is mostly dictated by the DNA.
An overview of the experimental and theoretical cross sections for the various complexes
is provided in Appendix 3.1. Results from our IMS-MS experiments and theoretical
docking studies are in good agreement with previous structural findings, in that NMR and
X-ray crystallography studies have reported that the –Arg-Gly-Arg– core of the AT-hook
peptide is buried into the minor groove of DNA, and that complexes are formed via
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Figure 6.1. Typical mobility profiles for the [M+4H]4+ and [M+5H]5+ charge states of
ATHP 1, 2, or 3 in complex with the DNA hairpin (FL876). The isotopic distribution for
each complex is shown (inset) and candidate structures for each complex are proposed.
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hydrogen bonds between the oxygen atoms of thymine and/or cytosine, while Van der
Waals forces govern interactions with adenines. 15, 18, 42 The lysines and arginines outside
of this core extend tightly along the DNA forming additional points of contact as a
result of electrostatic interactions with the negatively charged DNA phosphate
backbone.15, 18, 42
Comparison of the mobility distributions of the 1:1 and 2:1 peptide : DNA
stoichiometries suggest that the ATHPs bind to the AT-rich regions of the DNA in a single
“locked” conformation and that all three ATHPs are selectively stabilized upon binding to
the pre-formed FL876 hairpin (Scheme 2).43 The schematic model, determined using CCSs
from IMS, illustrates conformational changes of the peptide (i.e., unfolding) induced upon
minor and/or major groove substrate binding.44 From this process we begin building a
picture of the disordered-to-ordered transition of HMGA2 as it assemblies with DNA,
where the binding occurs indistinctly via the minor or major groove. Specifics regarding
the HMGA2:DNA complex will be further investigated utilizing IMS-MS methodology in
a following publication.
Scheme 2. Mechanism of ATHP attachment to DNA showing the preformed hairpin prior
to peptide unfolding upon binding.
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Figure 6.2. Typical mobility and isotopic distribution of DNA complexes. Single mobility
peaks were observed for all complexes and charge states. Specifically, the DNA and the
minor groove binding (MGB) Hoescht 33258 compound produced and [M+4H]+4 charge
state. ATHP 1 binding to the DNA-Hoescht complex produced [M+4H]+4 and [M+5H]+5
charge states. Proposed structures are also shown.
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Figure 6.3. Typical mobility profiles of ATHP 1, 2, or 3 in complex with the DNA hairpin
(FL876). Stoichiometry of 2:1 was observed at a [M+5H]+5 charge state. The isotopic
distribution for each complex is shown (inset) and candidate structures shown for the
FL876 hairpin in complex with ATHP1, ATHP2 and ATHP3.
Complexes were also probed using a variety of complementary solution-phase
techniques (e.g., DNA melting experiments, isothermal titration calorimetry (ITC) and
fluorescence measurements) and gas-phase collision induced dissociation (CID-MS) in
order to further evaluate our IMS findings. ATHP 1, 2 and 3 minor groove binding, via
fluorescent titration experiments, as a function of Hoechst 33258 compound displacement
was observed (Appendix 6.1).45 Specifically, increasing concentration of ATHP resulted
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in a decreased fluorescence signal, an indication of the Hoechst stain being sequentially
removed from the DNA minor groove and replaced with ATHP.
Hairpin formation was confirmed by a sharp DNA UV melting transition at 59 °C in 1×BPE
(see Figure 6.4a). The ATHPs 1- 3 showed a melting temperature (Tm) increase, indicative
of binding between each peptide and hairpin. The thermal stabilization of FL876 by ATHP
1 and ATHP 2 is greater than that caused by ATHP 3.
Results from ITC analysis support observations regarding the two binding site
hypothesis. Figure 6.4b shows the data retrieved from these experiments. A ‘normal’
titration curve was observed for all three peptides titrated into DNA. The enthalpy change
over the titration period was measured to determine exothermic vs. endothermic binding.
In fact, the DNA-binding enthalpy for ATHPs attaching in the major and minor grooves
was estimated.The binding of ATHP1 to FL876 is an exothermic reaction, which yields
negative enthalpies of -1.24 kcal mol−1 and -1.30 kcal mol−1 referring to binding sites one
and two (e.g., major or minor groove), respectively. In contrast, the binding of ATHP2 to
FL876 proved to be an endothermic reaction, with a positive enthalpy of 1.048 kcal mol −1
calculated for both of the binding sites. The titration of ATHP3 into FL876 also displayed
a 2:1 binding stoichiometry and the resulting exothermic reaction yielded negative
enthalpies of -1.17 kcal mol−1 and -1.71 kcal mol−1, respectively.
Complementary gas-phase, low energy collision induced activation experiments on
the [M+4H]+4 charge state of ATHP and FL876 1:1 complexes, were used to evaluate the
relative binding affinities (Figure 6.4c). As the collision energy increases, a decrease in the
molecular ion signal corresponding to the complex was observed; notice that collision
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Figure 6.4. a) DNA UV melting curves for uncomplexed FL876 and complexed FL876
with ATHP 1, 2 or 3 and b) ITC results determining the binding stoichiometry and affinity
of ATHP 1, 2 and 3 to both the major and minor groove of FL876 DNA and c) Collision
induced dissociation for FL876 complexed with ATHP1. ATHP2 or ATHP 3 (charge state
and degrees of freedom were considered) with the curve derivative shown as an inset.
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energy has been normalize to the charge and calculated per degree of freedom to account
for mass difference and charge between the experiments, a consideration supported through
previous work by Clemmers and co-worker.46 Comparison between the CID profiles of the
ATHP 1-3 : FL876 complexes shows that the weakest binding profile is observed for
ATHP 2 : FL876, followed by ATHP 3 : FL876 complex, and ATHP 1: FL876 complex.
We interpret these CID profiles in that as the collision energy increases, multiple collisions
with the collision gas (nitrogen in this case) leads to an increase in the vibrational modes
of the complex eventually leading to dissociation into the main constituents (i.e., ATHP
and FL876). That is, as the CID energy increases the internal energy increases until a
threshold is achieved, leading to complex dissociation. The increased energy needed to
begin dissociation of ATHP 1 : FL876 and ATHP 3 : FL876 distribution suggests that two
distinct binding sites (e.g., minor and major groove) are occupied. The more immediate
dissociation of the ATHP 2-FL876 complex suggest a predominant single binding site or
two weaker attachment sites. The CID profiles combined with the fluorescent titration and
ITC data indicate that ATHP 1, 2 and 3 can bind hairpin DNA and occupy both minor and
major grooves.
6.5 Conclusions
The high mobility resolution and trapping capabilities of TIMS-CID-TOF MS
allowed for the interrogation of ATHP 1, 2 or 3 in complex with hairpin FL876
conformational space. IMS-MS results showed that ATHP 1-3 can associate with DNA to
form a complex in a “locked” mechanism enabled by interactions of the –Arg-Gly-Arg–
tripeptide core and the AT-rich regions of the DNA duplex. Comparison of the ATHP 1-3
: FL876 DNA IMS profiles with candidate structures permitted the generation of a
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mechanistic description of the complex formation. The binding mechanism requires the
FL876 DNA to be pre-folded into a hairpin that will serve as substrate for the ATHP 1-3
attachment and transition from unstructured to structured. The experimental evidence from
TIMS-MS, UV melting studies, fluorescent titration, ITC, and CID-MS experiments infer
that the ATHP 1-3 peptides can indistinctively bind to the minor and major grooves of
FL876 DNA.
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CHAPTER 7: PEPTIDE SEQUENCE INFLUENCE ON THE
CONFORMATIONAL DYNAMICS AND DNA BINDING OF THE
INTRINSICALLY DISORDERED AT-HOOK 3 PEPTIDE
This chapter has been submitted on February 22, 2018 for publication in Scientific Reports
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7.1 Abstract
The intrinsically disordered ATHP3 was characterized at physiological conditions and
in complex with DNA using single amino acid substitutions and high-resolution ion
mobility spectrometry coupled to mass spectrometry (trapped IMS-MS). Results
showed that ATHP3 can exist in multiple conformations at physiological conditions (at
least 10 conformers were separated), where differences in the conformational space are
driven by the proline cis/trans orientation and the number and location of protons.
When in complex with AT rich DNA hairpins, the -RGRP- core is essential for
stabilizing the ATHP3 : DNA complex at physiological conditions. In particular, the
arginine in the sixth position plays the most important role during binding to AT-rich
regions of hairpin DNA, in good agreement with previous NMR and X-ray data.
Mobility based correlation matrices are proposed as a way to reveal differences in
structural motifs across the peptide mutants based on the conformational space and
relative conformer abundance.
The mammalian high mobility group protein (HMGA2, MW ~12 kDa), an
intrinsically disordered protein (IDP) that aids in the regulation and expression of
certain genes by influencing the remodeling of chromatin structure, 1-3 is also a known
oncofetal antigen,1, 4 biomarker of cell transformation and metastasis,5, 6 and a target in
cancer therapeutics.7, 8 In vivo studies have largely established the physiological role of
the full length HMGA2 by monitoring the effects of overexpression and knockouts in
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mice models.9 Specifically, HMGA2 gene amplification induces tumorigenesis, as
observed in several cancers, including leukemia,10 tongue cancer,11 lung cancer,12 breast
cancer,13, 14 and pituitary adenomas. 15 A pygmy phenotype was observed in null mice,6
whereas the truncated version of the protein is expressed in oversized mice.16 More
recently, in vitro analysis implicated HMGA2 in the process of aging
contains three positively charged motifs – known as “AT-hooks”
high affinity AT-rich DNA duplex regions
HMGA2 can easily form homodimers,

20

19

18

. HMGA2

17

- that bind with

and a negatively charged c-terminal tail.

an interaction most likely attributed to

contacts forming between the acidic c-terminal tail of one protein with the basic
residues of the counterpart protein, and interact with DNA and other proteins, making
HMGA2 a connected protein with a large interaction network.21 Despite progress made
using in vivo and in vitro studies, only few studies have contributed to the structural
characterization (e.g., NMR and crystallography studies of ATHP2 and ATHP3 bound
to duplex DNA).22, 23
Ion mobility spectrometry and mass spectrometry (IMS-MS) have shown the
advantages of these techniques for structural biology, and more specifically, for the
study of biomolecules and biomolecular complexes.24-27 IMS-MS has addressed specific
shortcomings of current conventional methods of structural analysis (i.e. NMR and Xray crystallography) by reducing analysis time, sample consumption, sample purity
requirements and restriction on biomolecule flexibility.28,
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29

IMS-MS has gained

attention for the study of dynamic proteins in their native, partially folded and
unfolded forms

24, 30-32

and when complemented with molecular dynamic simulations

has allowed the identification of specific intramolecular interactions that stabilize
conformational states (i.e. proline and side-chain orientation, protonation site).33 IMSMS can capture conformational interconversions and intermediate states for peptides,
proteins, DNA and complexes.24, 25, 34 For example, in a recent study, the influence of
solvent composition and time after desolvation dynamics on the ATHP3
conformational space was reported.33 At the protein level, it has been shown that
phosphorylation of the c-terminal tail can play a vital role during HMGA2 proteinprotein and protein-DNA interactions.35
In the present study, the peptide sequence influence on the conformational
space and DNA binding for the intrinsically disordered ATHP3 is studied using trapped
IMS coupled to mass spectrometry (TIMS-CID-TOF MS) and single amino acid
substitutions. A discussion on the conformational space as a function of the charge
location and proline orientation and binding affinity to DNA follows.
7.2 Results and Discussion
Under native conditions, three charge states in positive ion mode ([M+H]+ to
[M+3H]3+) were observed for the ATHP3 and the seven amino acid substituted peptides
(see corrected CCS profiles and fingerprint in Figure 7.1 a-b). A correlation matrix of
the IMS fingerprints (Figure 7.1c) is used for rapid comparison and identification of the
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single amino acid substitution with the smallest/largest influence in the ATHP3
mobility profile at physiological condition (first column and first row), as well as
between the mutants using equation 3. For example, following the color scale, P3A and
R8A are the most and R2A is the least closely related mutants to ATHP3. That is, a
quick assessment of the influence of the primary sequence (e.g., single amino acid
substitution) on the peptide secondary structure can be observed.
One of the advantages of using single point residue mutations in combination
with IMS-MS, is the possibility to identify the conformational state of the prolines
(cis/trans) as well as the charge location for the case of the basic residues by comparison
of the corrected IMS profiles.26 While it is known that prolines in the trans position are
energetically more favorable than in the cis position (95% of the time, being ~0.5
kcal mol-1 lower in energy with ~13 kcal mol-1 barrier),45 when substituted by alanine
which is energetically more favorable in trans position (~2.5 kcal mol-1 lower in energy
with ~20 kcal mol-1 barrier),45 allows for the determination of the ATHP3 state by
looking at the conservation (proline in trans) or absence (proline in cis) of the IMS
band.26 That is, comparison of the corrected profiles for ATHP3 and for P3A and P7A
permits the assignment of the proline in ATHP3 for the different bands observed
(results summarized in Table 1). Analogous, single point mutations of the basic residues
allow the assignment of the charge. In the case of the ATHP3, up to seven protons can
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Figure 7.1. Typical, normalized ATHP3 and corrected variant (*) mobility profiles for the
[M+H]+, [M+2H]2+ and [M+3H]3+ for intrinsic size parameters upon residue substitution
to alanine (a). Peptide IMS fingerprint (b) and correlation matrix (c) are used for
assessment of the primary sequence effect on the secondary structure.
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be attached; however, during native conditions (pH ~ 6.7), a maximum of three protons
were observed. That is, the high number of IMS bands can be attributed to different
locations of the proton (i.e., protomers) in addition to the potential constraints
generated from the proline configuration. Comparison of the ATHP3 profile with those
of R2A, R4A, R6A and R8A permitted the assignment of the number and position of
the charge in the intrinsically disordered ATHP3. Moreover, knowing the total charge
and number of protons per band, the protonation probability of the N-term and the
lysine at position one was calculated (difference from the charge state and number of
protonated arginines). In addition to this information, the W10A substitution provides
insight in the role of the tryptophan on the overall conformational space.
Inspection of Table 1 shows that ATHP 3 [M+H]+ conformers (i.e., A and B
bands) differ in the orientation of P3 (trans vs cis) and the location of the charge (R8 vs
N-term/K).
In the case of ATHP 3 [M+2H]+2, differences between the five bands (C-G) are
also associated to the orientation of the prolines P3 and P7 and the protonation of the
basic residues R2, R4, R6 and R8. In the case of ATHP [M+3H]+3, differences between
the five bands (H-J) are associated to the proline P7 and the protonation of the basic
residues R2,
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Table 7.1. Summary of charge location and cis/trans proline configuration of the Native
ATHP3 per IMS band (A-J).
A

B

C

D

E

F

G

H

I

J

R2

N

N

+

+

+

+

+

N

+

+

P3

trans cis
*

trans

trans

trans
*

trans

cis

Cis

cis

cis

R4

N

N

+

+

+

+

+

+

+

+

R6

N

N

+

+

N

N

+

+

+

+

P7

trans trans

trans

trans

cis

cis

cis

Cis

trans
*

trans
*

R8

+

N

N

N

N

+

+

N

+

N

W10

-

-

-

-

-

*

*

*

-

-

Nter/K

N

+

N

N

N

N

N

+

N

+

Residu
e

R4, R6 and R8. While in some cases the charge residue that is protonated can be
uniquely assigned, for the case of the IMS band I there are at least two protonation
patterns that yield the same CCS value; that is, different protonation patterns can share
the same IMS band. In summary, the data presented in Table 1 shows that the
intrinsically disordered ATHP3 can exist in a variety of conformations (at least 10),
where the proline configuration and the charge location drive the intramolecular
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interactions that stabilizes the peptide secondary structure in multiple kinetic
intermediates.
Peptide-DNA complexes were formed in solution and observed in the gas-phase
at [M+4H]4+ and [M+5H]5+ charge states under native spray conditions for all considered
peptide mutants (Figure 7.2a). Beside the peptide-DNA complexes, unbound DNA and
peptides were also observed at [M+3H]3+ - [M+4H]4+ and at [M+H]+ - [M+3H]3+charge
states, respectively. The relative abundance of unbound peptide and DNA was
consistently higher for the [M+2H]2+ and [M+4H]4+ charge states, respectively. IMS
profiles of the peptide-DNA complexes (Figure 7.2b and 7.2c) can be characterized by
a single, broad mobility band - depicting a comparatively stable complex. The IMS peak
width was consistent as a function of the charge states and the differences in CCS
between the [M+4H]4+ and [M+5H]5+ charges suggest that no conformational
rearrangements occur with the charge states (~20-100 Å2). Inspection of the peptideDNA fingerprint plots, generated from the corrected IMS profiles, allows for a quick
description of the influence of the single amino acid substitution on the structure of
the peptide-DNA complex (Figure 7.2c). Further information can be extracted from the
correlation matrix (Figure 7.2d). If the single amino acid substitution does not
dramatically affect the corrected IMS profiles (similar fingerprint) or has a high
correlation value, the most likely this amino acid has a lower role during the peptide DNA complex formation and is not an active participant in the binding site. For
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example, comparison of the ATHP3 and the R2A/R4A/R8A/W10A peptides shows
higher similarities and correlation values, which suggest that these amino acids are less
likely to regulate and participate in the peptide-DNA complex interaction. Moreover,
P3A/R6A/P7A showed larger differences

Figure 7.2. Typical mass spectra (a) and ‘corrected’ ion mobility profiles (b) of the native
and substituted ATHP3 : DNA complexes. The IMS profile fingerprint (c) of the
complexes was used to generate a correlation matrix (d). Values reported in (a) correspond
to peptide : DNA : complex ratios.
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and lower correlation values, which suggest that there are most likely involved in the
peptide-DNA complex interaction. These observations are in good agreement with
previous NMR results that suggest that the -PRGRP- core most likely interacts with
the DNA.22 A crystal structure of the ATHP3 in complex with duplex B-form DNA
revealed that the central core arginine residues protrude inward creating hydrogen
bonds from the amino acid NH atom to the thymine oxygen atom.23
A complementary way to evaluate the influence of each amino acid on the
ATHP3 : DNA complex is through the inspection of the dissociation curve as a function
of the collision energy (Figure 7.3a). The assumption is that the rupture of the
intramolecular interactions that stabilizes the peptide-DNA complex using single
amino acid substitutions will result in different collision energies required to disrupt
the complex. Inspection of Figure 7.3a shows that the R6A peptide
presents the largest change in dissociation profiles, which suggest that the arginine in
the sixth position is essential for the stabilization of the ATHP3 : DNA complex in the
-RGR- core, in good agreement with previous NMR observations.22, 46
The probability of peptide : DNA complex formation (or binding affinity) can
also be evaluate by the differences in the relative abundance of the product (i.e.,
complex) with respect to the initial reactants (i.e., peptide and DNA) using equation 4
and 5 (Figure 7.3b and 7.3c). Inspection of Figure 7.3b and 3c shows that the
substitutions R2A/P3A/W10A has higher binding affinity (Ka) relative to the ATHP3
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peptide, while the substitutions R4A/R6A/P7A has lower binding affinity compared to
the ATHP3. These results suggest that R4A/R6A/P7A are directly related to the
ATHP3 : DNA complex formation.

Figure 7.3. Typical CID profiles (a) showing the decrease in intensity of the [M+4H]4+
peptide : DNA complexes as a function of collision energy (eV), charge (z) and degrees of
freedom (DoF). The dissociation threshold (inset) shows the absolute derivative of each
CID profiles as a function of the collision energy. The binding affinity (b) and distance
matrix (c) illustrates the influence of the single amino acid substitution on the peptideDNA binding affinity.
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The intrinsically disordered ATHP3 peptide in complex with DNA was studied
using single amino acid substitutions and IMS-MS at physiological conditions. Seven
amino acid substitutions were considered and changes in the peptide and peptide-DNA
complexes conformational space as well as their relative abundance and dissociation
kinetics were used to establish the amino acid positions that stabilize the ATHP3 : DNA
complex formation in solution. The high resolution of the trapped IMS (TIMS) analyzer
permitted the observation of multiple IMS bands for the intrinsically disordered
ATHP3 peptide (at least 10 conformers). Using the corrected IMS profiles, the proline
orientations (cis-trans) and charge location (basic residues and N-terminal) per IMS
band were determined, providing a detailed description of the intramolecular
interactions that describe the ATHP3 conformational space. These studies provided
significant insight on the critical role of cis and trans proline configurations and charge
locations in the populations of ATHP3 structures that are observed in physiological
conditions.

The study of peptide-DNA complexes suggests that the -RGRP- core is essential
for stabilizing ATHP3 : DNA complex at physiological conditions. Moreover, it was
shown that weakest peptide : DNA complex is form with R6A, suggesting that this basic
residue plays the most important role during binding to AT-rich regions of the DNA,
in good agreement with previous NMR and X-ray data.22, 23
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It should be noted that the IMS-MS workflow permits the study of multiple
kinetic intermediates simultaneously, in contrast to the most abundant (or
energetically favored) typically described using NMR and X-Ray measurements. This
makes IMS-MS a powerful platform for the study of intrinsically disordered
biomolecules and their kinetic intermediates. This work highlights the potential of
IMS-MS combined with single amino acid substitutions for the evaluation of the
peptide primary sequence influence on the secondary structure at physiological
conditions. When combined with CID-MS, this workflow can be translated to the
study of peptide complex conformations.

7.2 Experimental Methods
7.2.1 Sample preparation
Native AT-hook peptide 3 (Lys-Arg-Pro-Arg-Gly-Arg-Pro-Arg-Lys-Trp) and all amino
acid substituted peptides were purchased from GenScript and used without further
purification.

An

AT-rich

DNA

oligomer,

denoted

as

FL876,

sequence

GGATATTGCCCCCGCAATATCC (C212H270N79O130P21, MW 6655.1561) was purchased
from Eurofins Genomics (Luxembourg City, Luxembourg) and used as received. This
22 nucleotide DNA hairpin contains a 9 base pair stem comprised of a 5 base pair AT
rich region in the middle of the stem. Solvents and ammonium acetate salts utilized in
this study were analytical grade or better and purchased from Fisher Scientific

163

(Pittsburgh, PA). A Tuning Mix calibration standard (G24221A) was obtained from
Agilent Technologies (Santa Clara, CA) and used as received.

7.2.2 Peptide nomenclature
The amino acid sequence of the ATHP3 and variants are presented in Appendix 7.1,
along with the nomenclature followed throughout the text. Specifically, the variant
peptides are referred to by the original amino acid residue followed by their position
and the replacement amino acid in a single-code nomenclature.

7.2.3 Ion Mobility Spectrometry-Mass Spectrometry
Details regarding the trapped IMS (TIMS) operation and specifics compared to
traditional IMS can be found elsewhere.33, 36-39 Briefly, a custom nESI-TIMS unit was
coupled to a Maxis Impact Q-TOF mass spectrometer (Bruker, Billerica, MA). The
TIMS unit is run by custom software in LabView (National Instruments) synchronized
with the MS platform controls. Sample aliquots (10 L) were loaded in a pulled-tip
capillary biased at 700-1200 V to the MS inlet. The nitrogen bath gas flow is defined by
the pressure differential between the entrance funnel (P1 = 2.6 mbar) and the exit
funnel (P2 = 1.1 mbar) at ca. 294 K. A 880 kHz and 200 Vpp RF potential was applied.
Deflector, capillary, entrance funnel, entrance and exit analyzer voltages were 60, 50,
0, -200-0, and 60 V in positive mode (and -60, -50, 200-0, and -60 V in negative mode)
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to prevent ion heating prior to IMS separation. The reduced mobility, K, of an ion in a
TIMS cell is described by:

𝐾=

𝑉𝑔
𝐸

𝐴

 (𝑉

(1)

𝑒𝑙𝑢𝑡𝑖𝑜𝑛 −𝑉𝑜𝑢𝑡 )

where vg, E, Velution and Vout are the gas velocity, applied electric field, elution voltage
and exit analyzer voltage, respectively. After thermalization, species were eluted from
the TIMS cell by decreasing the electric field in stepwise decrements (referred to as the
“ramp”) and can be described by a characteristic elution voltage ( Velution). The mobility
calibration constant A was determined using known reduced mobilities of Tuning Mix
components (K0 of 1.013, 0.835, and 0.740 cm2/(V.s) for respective m/z 622, 922, and
1222). The scan rate (Sr=Vramp/tramp) was optimized for every experiment.

The measured mobilities were converted into CCS (, Å²) using the Mason-Schamp
equation:

𝛺=

(18𝜋)1/2
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[ +𝑚 ]
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(2)

𝐾0 𝑁 ∗

where z is the charge of the ion, kB is the Boltzmann constant, N* is the number density
of the bath gas and mi and mb refer to the masses of the ion and bath gas, respectively.
TIMS-MS spectra were analyzed using Compass Data Analysis 5.0 (Bruker Daltonik

165

GmbH) and TIMS Data Viewer 1.4.0.31397 (Bruker Daltonik GmbH). The IMS
corrected profiles were compared using the correlation coefficient function:

𝐶𝑜𝑟𝑟𝑒𝑙 (𝑋, 𝑌) =

∑(𝑥−𝑥̅ )(𝑦−𝑦̅)

(3)

√∑(𝑥−𝑥̅ )2 (𝑦−𝑦̅)2

where 𝑥̅ and 𝑦̅ are the sample means average for IMS profile 1 and 2.

7.2.4 Correction of amino acid substituted collision cross sections
For direct comparison of the mobility profiles between the ATHP 3 and single amino
acid substituted peptides (e.g. Arg to Ala, Pro to Ala and Trp to Ala), the CCS profiles
were adjusted based on the method previously described in references.26, 40, 41 To account
for differences in CCS between N2 and He, the CCSN2 = 1.0857 (CCSHe) + 81.459 [Å2]
conversion was used.42,

43

This resulted in Arg to Ala, Pro to Ala and Trp to Ala

substitutions to be corrected by 17.43 Å2, 2.68 Å2 and 17.43 Å2 in N2, respectively.
Because the tryptophan residue CCS has not been previously reported, the Arg value
was used instead considering the similarity between the geometries and steric
hindrances.

Determination of binding affinities. Peptide-DNA binding affinities (Ka) were
calculated, using the general equation for an association reaction, based on the peak
area of the complex divided by the peak area of the unbound DNA and unbound
peptide.44
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(𝐶𝑜𝑚𝑝𝑙𝑒𝑥)

Ka = (𝐷𝑁𝐴)(𝑃𝑒𝑝𝑡𝑖𝑑𝑒)

(4)

A distance matrix was utilized to better evaluate relative changes associated with the
single amino acid substitution using the equation:

𝐾𝑎(𝑝𝑒𝑝𝑡𝑖𝑑𝑒 ) −𝐾𝑎(𝑝𝑒𝑝𝑡𝑖𝑑𝑒𝑌 )
𝑋
]
< 𝐾𝑎𝑝𝑒𝑝𝑡𝑖𝑑𝑒 (1−8) >

D(X,Y)=[

(5)
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CHAPTER 8: MICRO HETEROGENEITY OF TOPOISOMERASE IA/IB AND
THEIR DNA-BOUND STATES
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8.1. Introduction
DNA topoisomerases are ubiquitous enzymes, present in every organism, that
manage and control DNA topology, both globally and locally.1 Topoisomerases are
essential proteins for DNA strain release from supercoils during replication and
transcription, thus warrantying proper super helical density for essential cellular functions
not disturbed.2 Recent studies have verified bacterial topoisomerase I as a viable and novel
target utilized for the discovery of new antibiotics.3 A main roadblock is the lack of a three
dimensional structure for the topoisomerase proteins and their DNA-bound forms. The
success of traditional structural biology approaches (e.g., NMR and x-ray crystallography)
have been limited to the description of subdomains or DNA-bound subdomains.4-6 As a
result, there is a need for alternative approaches to describe the multistep mechanism
consisting of DNA binding, cleavage and strand religation.
Native mass spectrometry (MS), and more recently in combination with ion
mobility spectrometry (IMS), have provided unique insights in structural biology during
the study of biomolecules and biomolecular complexes in the absence of the bulk solvent.78

In particular, IMS-MS has addressed specific shortcomings of current conventional

methods by reducing the analysis time, sample consumption, sample purity requirements
and restrictions on the biomolecule flexibility. Due to these unique advantages, IMS-MS
has gained great attention for the study of protein dynamics in their native, partially folded
and unfolded forms8-1024,30-32, and when complemented with molecular dynamic
simulations, has allowed the identification of specific intramolecular interactions that
stabilize conformational states.11
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IMS-MS can capture conformational interconversions and intermediate states for
peptides, proteins, DNA and complexes.8-9, 122 For example, in a recent study, the influence
of solvent composition and kinetically trapped intermediates on the intrinsically disordered
ATHP3 conformational space was reported.11 For DNA bounding proteins, IMS-MS
studies have described the dimerization of the intrinsically disordered HMGA2 protein,13
as well as that phosphorylation of the c-terminal tail can play a vital role during HMGA2
protein-protein and protein-DNA interactions.14
In this paper, we utilized a second generation trapped IMS coupled to MS for the
study of topoisomerase IA and IB and their DNA bound states. The higher trapping
efficiency and mass range of the new TIMS-MS instrument allowed the separation of
conformational microstates for the topoisomerases and their DNA-protein complexes. In
particular, first principle ion-neutral collision cross sections are reported for topoisomerase
IA and IB, and their DNA bound states with a 13 base single strand DNA (ssDNA) and a
59 base stem loop DNA substrate (MBLong2). This experimental evidence shows the
flexible nature of topoisomerases IA and IB.
8.2 Experimental Methods
8.2.1 Materials and reagents
A 13 base (Sub 1) and 59 base (MBLong2) DNA oligomer sequence 5’AATGCGCTTTGGG-3’

(C128H161N49O78P12,

MW

4005.71)

and

5’-

GCCCTGAAAGATTATGGAATGCGATTAGGGT
AAAGGAAGAGAGCATAATCTTTCAGGGC-3’ (C582H722N240O345P58, MW: 18396.14)
was purchased from Biosearch Technologies (Petaluma, CA) and dialyzed in 100 mM
ammonium acetate prior to analysis. Sub 1 is a single-stranded DNA, while MBLong2
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forms a stem loop structure consisting of 16 base pair stem and 27 base loop. E. coli
topoisomerase I (sequence: UniProt P06612) was purified and vaccinia topoisomerase IB
(sequence: UniProt P68697) were purified as recombinant proteins. Water and ammonium
acetate salts utilized in this study were analytical grade or better and purchased from Fisher
Scientific (Pittsburgh, PA). A Tuning Mix calibration standard (G24221A) was obtained
from Agilent Technologies (Santa Clara, CA) and used as received.
8.2.2 Trapped Ion Mobility Spectrometry – Mass Spectrometry Analysis (TIMS-MS)
Details regarding the TIMS operation and specifics compared to traditional IMS can be
found elsewhere.15-19 Briefly, mobility separation in TIMS is based on holding the ions
stationary against a moving gas using an electric field. The separation in a TIMS device
can be described in the center of the mass reference frame using the same principles as in
a conventional IMS drift tube.20 Since mobility separation is related to the number of ionneutral collisions (or drift time in traditional drift tube cells), the mobility separation in a
TIMS device depends on the bath gas drift velocity, ion confinement and ion elution
parameters. The reduced mobility, K, of an ion in a TIMS cell is described by:
𝐾=

𝑉𝑔
𝐴
=
𝐸
(𝑉𝑒𝑙𝑢𝑡𝑖𝑜𝑛 − 𝑉𝑜𝑢𝑡 )

where vg and E are the velocity of the gas and the applied electric field across the TIMS
analyzer region. Velution is the voltage when the ions elute in the Vramp sweep and Vout is
the voltage applied at the end of the TIMS analyzer region.
A custom-built, pulled capillary nanoESI source was utilized for all the
experiments. Quartz glass capillaries (O.D.: 1.0 mm and I.D.: 0.70 mm) were pulled
utilizing a P-2000 micropipette laser puller (Sutter Instruments, Novato, CA) and loaded
with 10 L aliquot of the sample solution. Sample solutions consisted of 5-10 µM enzyme
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in 100 mM ammonium acetate solution at native pH (pH = 6.7). For the observation of the
complexes, a 1:1 ratio of 5 µM concentration of the DNA and enzyme was prepared in
100mM ammonium acetate immediately prior infusion. A typical nanoESI source voltage
of +/- 600-1200 V was applied between the pulled capillary tips and the TIMS-MS
instrument inlet. Ions were introduced via a stainless steel tube (1/16 x 0.020’’, IDEX
Health Science, Oak Harbor, WA) held at room temperature into the TIMS cell.
Mobility calibration was performed using the Tuning Mix calibration standard
(G24221A, Agilent Technologies, Santa Clara, CA) in positive ion mode (e.g., m/z = 322,
K0 = 1.376 cm2 V-1 s-1 and m/z = 622, K0 = 1.013 cm2 V-1 s-1).19 The TIMS operation was
controlled using in-house software, written in National Instruments Lab VIEW, and
synchronized with the maXis Impact Q-ToF acquisition program.15-16
Reduced mobility values (K0) were correlated with CCS (Ω) using the equation:
Ω=

(18𝜋)1/2
𝑧
1
1 1/2 1 1
[
+
]
16 (𝑘𝐵 𝑇)1/2 𝑚𝑖 𝑚𝑏
𝐾0 𝑁 ∗

where z is the charge of the ion, kB is the Boltzmann constant, N* is the number density
and mI and mb refer to the masses of the ion and bath gas, respectively.20
8.3 Results and Discussion
In order for topoisomerase enzymes to regulate DNA supercoiling they need to
exist in a variety of conformations. The proposed action for type IA and IB topoisomerases
are two very different modes of operation - an enzyme-bridged, strand-passage
mechanism21 and a strand rotation model,22 respectively. However, structural information
regarding the dynamics of topoisomerases as they process DNA supercoils is limited
because of the inherent flexibility of the domains. To better understand the proposed
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mechanism of DNA cleavage by topoisomerase we took advantage of the sensitivity and
high mass (~100 kDa) capabilities of the TIMS-MS technique to probe for the presence of
multiple conformational isomers. We analyzed E. coli topoisomerase IA (EcTopI) and
eukaryotic vaccinia virus topoisomerase IB (vTopIB). Both of these enzymes are of
particular interest because they are structurally distinct from each other, therefore allowing
us to observe two different mechanistic pathways of conformational change.
Mass spectrometry analysis of the 36 kDa vaccinia topoisomerase IB enzyme
shows the existence of two main charge state distributions (CSDs), one centered at high
m/z values (+12) and the other at lower ones (+17, +24 or +28) (Figure 8.1 and appendix
8.1). Performed at near-native pH conditions (pH=6.7), vTopIB can simultaneously assume
both a low and high-charged CSD, relating to compact/native conformations or
extended/denatured conformations, respectively (appendix 8.1). Mobility analysis of all
observed charge states exhibited a distribution of conformations, spanning a range of 3000
to 9800 Å2, from native to partially folded, and finally to denatured states. The ‘nativelike” IMS distributions for topoIB are observed at charge states +10 to +13 (Figure 8.1). A
phase transition at +13 towards conformational open states was observed, followed by
more extended structures at +29 to +35. The high IMS resolving power of the TIMS
analyzer allowed the observation of multiple stable IMS bands (often two broad
conformers) and insight into the conformational transition pathways. Moreover, inspection
of the +14 to +35 charge states exhibited a widening of IMS band distributions when
compared to the +10 to +13 charge states, indicating more conformational flexibility of the
extended structures (appendix 8.1).
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Assessment of the x-ray structure of vTopIB, in conjunction with DNA,23 shows
that a flexible linker connects the N-and C-terminal domains, allowing both ends of the

Figure 8.1. a) Typical mass spectra of all charge states observed under native starting
solvent conditions, and (b) the mobility profiles for the native (+10 to +13) and partially
folded forms (+13 to +21) of unbound vTopIB. The structure presented is a modified
version pdb 3IGC,24 without the DNA substrate
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enzyme to surround the DNA substrate and form contacts on opposite sides of the duplex.25
This information allows us to better understand the movements that govern the ‘nativelike’ and more conformers of vTopIB. In particular, we deduce that movements of domains
away from each other due to Coulombic repulsion may initially stem from this region,
which in the absence of DNA, is not stabilized.
Evaluation of the 97 kDa E.coli topoisomerase I enzyme by TIMS-MS provided
information on the structural dynamics of the compact conformers. Specifically,
experiments carried out at near-native conditions (pH = 6.7) probed only the ‘native-like’
states. Six charge states (e.g., +16 to +21) were populated with CCSs ranging from 5250
Å2 to 6500 Å2 (Figure 8.2a and b). A pattern of conformational change, identified by five
transition states, was observed under these solvent conditions. Moreover, slight opening of
the enzyme, followed by conformational change back to a more compact structure is
observed, most notable for charge states +16 and +18, respectively. This peculiar trend of
opening and closing, as a function of charge state, can give insight into the mechanism of
conformational change and inter-molecular interactions that stabilize EcTopI. The flexible
nature of EcTopI is evident by the variety of gas-phase stable conformers. The most
populated ion conformer (+19) exists as a broad conformational distribution of ~750 Å 2.
The +18 and +20 charge states are also broad, showing three and two resolved
conformational isomers, respectively. Ultimately, the mobility data of the free EcTopI are
in good agreement with previous studies26 which indicate that the overall arrangement of
the enzyme domains can change in a dramatic way. For example, the hinge between
domains II and IV may regulate the opening and closing of the N-terminal domains.4
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Figure 8.2. a) Typical mass spectra of all charge states observed under native starting
solvent conditions, and (b) the mobility profiles for the native (+16 to +21) state of unbound
EcTopI. The structure presented is a modified version pdb 4RUL, without the DNA
substrate.
Comparison of the CSDs and mobility profiles of vTopIB and EcTopI illustrate
some obvious differences, relating specifically to the disparity of each enzymes size (36
kDa vs. 97kDa, respectively). However, closer analysis reveals that charge state unfolding
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of the vTopIB native conformers are more easily induced in comparison to EcTopI. We
further predict that the greater conformational flexibility of free vTopIB is most likely
attributed to the motion of the inter-domain hinge region,27 or the protease-sensitive
bridge,28 and that greater intramolecular interactions are present in EcTopI that stabilize it
in a compact form.
Gas-phase IMS-MS analysis of unbound vTopIB and EcTopI can be followed by
study of the enzyme-DNA complex. The interaction of topoIB with duplex DNA occurs
via a single-strand break to form a covalent bond between the catalytic tyrosine and the 3'phosphoryl end of the broken strand. IMS studies reveal the formation of the complex at
charge states +12 to +14 (Figure 8.3a and b). Interestingly, each mobility band is at least
500 Å2 wide. The presence of such broad conformational ensembles is indicative of several
closely related conformational structures which have similar CCS values. We observe,
however, narrowing of the mobility bands as the charge increases (e.g., +12 versus +14).
Comparison of the +12, +13 and +14 charge states of both the unbound and DNA bound
enzyme reveal that the complex achieves a more compact conformation. That is, the DNA
stem loop induces folding of vTopIB. The formation of vTopIB into a folded C-shaped
clamp, enveloping both the major and minor grooves of DNA, is strongly supported by
TIMS-MS analyses.
Due to the inherent flexibility of EcTopI, structural analysis by means of traditional
techniques often prove difficult. However, in 2015, a near complete x-ray structure of
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Figure 8.3. a) Typical mass spectra, and (b) mobility profiles for the native states (+12 to
+14) of vTopIB in complex with a 59 base stem loop DNA substrates (MBLong2), as a
function of native starting solvent conditions.
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EcTopI in complex with ssDNA was published, providing important insight into the
multistep catalytic cycle responsible for removing negative DNA supercoils.4 Briefly, more
details regarding the action of the N-terminal domain (ssDNA cleavage and rejoining), and
the C-terminal domain (passing of the intact strand through the enzyme-bridged gate) were
provided. Complementary gas-phase studies can offer another level of possible data
interpretation. For example, our mass spectrometry studies revealed four charge states (+17
to +20) exhibiting a 1:2 binding stoichiometry of EcTopI enzyme to sub

Figure 8.4. a) Typical mass spectra, and (b) mobility profiles for the native states (+17 to
+20) of EcTopI in complex with two ssDNA substrates (2x sub 1), as a function of native
starting solvent conditions.
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1 DNA, respectively (Figure 8.4a). Inspection of the IMS profiles shows that the two 13base ssDNA substrates act to inhibit and prevent the opening of the enzyme (Figure 8.4b).
In fact, the only evidence for formation of a more open strucutre, as a function of
charge state, is the two low abundant conformers at +20. It should be noted that 1:1
complexes were not observed. Next, we characterized the complex between the 50 base
DNA stem loop (MBLong2) and EcTopI. Under native conditions, six charge states were
formed (+17 to +22) at a 1:1

Figure 8.5. a) Typical mass spectra, and (b) mobility profiles for the native states (+17 to
+22) of EcTopIBin complex with a 59 base stem loop DNA substrates (MBLong2), as a
function of native starting solvent conditions.
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stoichiometry (Figure 8.5a). Inspection of the corresponding conformers exhibited
narrower distributions, when compared with EcTopI-2xSub1 (Figure 8.5b).
Comparison of the three topoisomerase-DNA complexes (e.g. vTopIB-MBLong2, EcTopI2xSub1, EcTopI-MBLong2) shows that although the charge states, CCSs and overall
conformations are significantly different, there are similarities. In particular, binding to
DNA reduces the flexibility of the enzyme and, in the case of vTopIB-MBLong2, actually
leads to slightly more compact structures.
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Appendix 2.1
Full protein sequences from which peptides were identified based on accurate m/z and
mobility. Determined sequence coverage was based only on fractions analyzed.

191

Appendix 2.2
Peptides corresponding to targeted proteins, identified through discovery-based
measurements. Observed mass, adduct and protein sequence coverage are reported.

Protein Target

Peptide

Mass (Da)

Adduct

Calmodulin

MADQLTEEQIAEFK

1651.78

[M+2H]+2

Calmodulin

ADQLTEEQIAEFK

1520.74

[M+2H]+2

Calmodulin

ADQLTEEQIAEFKEAFSLFDK

2458.19

[M+3H]+3

Calmodulin

EAFSIFDK

955.47

[M+H]+

Calmodulin

EAFSIFDKDGDGTITTK

1843.88

[M+2H]+2

Calmodulin

DGDGTITTK

906.43

[M+H]+

Calmodulin

ELGTVMR

804.42

[M+H]+

Calmodulin

MKDTDSEEEIR

1351.59

[M+2H]+2

59.7

+

Calmodulin

DTDSEEEIR

1092.46

[M+H]

Calmodulin

DTDSEEEIREAFRVFDK

2084.97

[M+2H]+2

Calmodulin

EAFRVFDK

1010.52

[M+H]+

Calmodulin

VFDKDGNGYISAAELR

1753.86

[M+2H]+2

Calmodulin

DGNGYISAAELR

1264.60

[M+2H]+2

Calmodulin

HVMTNLGEK

1027.51

[M+2H]+2

Calmodulin

LTDEEVDEMIR

1348.62

[M+2H]+2

DJ-1

GAEEMETVIPVDVMR

1674.80

[M+2H]+2

DJ-1

VTTHPLAK

865.50

[M+H]+

DJ-1

DGLILTSR

873.49

[M+H]+

DJ-1

EQENRK

802.39

[M+H]+

DJ-1

GPGTSFEFALAIVEALNGK

1920.00

[M+2H]+2

Progesterone

GDQPAASGDSDDDEPPPLPR

2034.88

[M+3H]+3

Progesterone

FYGPEGPYGVFAGR

1515.71

[M+2H]+2

Progesterone

DFTPAELR

947.47

[M+H]+

Progesterone

ILMAINGK

858.50

[M+H]+

Progesterone

GLATFCLDK

966.48

[M+H]+

Progesterone

VFDVTK

707.39

[M+H]+
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(%)

24.9

17.4

Progesterone

YHHVGK

739.38

[M+H]+

Parafibromin

ADVLSVLRQYNIQK

1645.92

[M+2H]+2

Parafibromin

ADVLSVLRQYNIQKK

1774.01

[M+2H]+2

Parafibromin

GDEVIFGEFSWPK

1509.71

[M+2H]+2

Parafibromin

TNYVVWGTGK

1123.57

[M+2H]+2

Parafibromin

RAATENIPVVR

1224.69

[M+H]+

Parafibromin

IEDEECVRLDKER

1632.78

[M+2H]+2

Parafibromin

DLLGYLNGEASTSASIDR

1880.91

[M+2H]+2

Parafibromin

LMPQDWDR

1059.48

[M+H]+

Parafibromin

RAADEVIAEAK

1171.62

[M+2H]+2

Parafibromin

FWETLDR

965.46

[M+H]+

Parafibromin

AADEVLAEAK

1015.52

[M+H]+

Parafibromin

EGIVQTEQIR

1171.62

[M+2H]+2

Parafibromin

TDIDDDITAIK

1218.60

[M+2H]+2

Parafibromin

SFVDAEVDVTR

1236.60

[M+2H]+2

Parafibromin

TKQPIPAAYNR

1257.68

[M+2H]+2

Parafibromin

QPIPAAYNRYDQER

1719.83

[M+2H]+2

Parafibromin

GKEETEGFK

1023.49

[M+H]+

Parafibromin

SVTEGASAR

876.43

[M+H]+

Parafibromin

DLLQDLK

843.47

[M+H]+

Parafibromin

FVPSDEK

820.40

[M+H]+

Parafibromin

QGCQRENETIIQR

1573.76

[M+2H]+2

Parafibromin

WDVTVLELSYHK

1488.76

[M+2H]+2

Parafibromin

RHLDRPVFLR

1307.76

[M+2H]+2

Parafibromin

HLDRPVFLR

1151.66

[M+2H]+2

Parafibromin

FWETIDRYMVK

1486.73

[M+2H]+2

Parafibromin

FWETLDR

965.46

[M+H]+

MAP-7

LSASTASELSPK

1189.62

[M+2H]+2

MAP-7

ESPSAAGPEDKSQSK

1516.70

[M+2H]+2

MAP-7

DKER

546.28

[M+H]+

MAP-7

AQAEQEEQERLQK

1585.77

[M+2H]+2

MAP-7

AQAEQEEQER

1216.53

[M+2H]+2
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42.6

15.1

MAP-7

SAVTLPRNGR

1069.60

[M+2H]+2

MAP-7

SEVSETKQK

1034.52

[M+2H]+2

MAP-7

REER

588.30

[M+H]+

MAP-7

SSATLWNSPSR

1204.58

[M+2H]+2

MAP-7

GPQPDR

668.32

[M+H]+

MAP-7

ARLSASTASELSPK

1416.76

[M+2H]+2

MAP-7

ESPSAAGPEDK

1086.48

[M+2H]+2

MAP-7

GPTWGR

672.33

[M+H]+

MAP-7

SEVSETK

778.37

[M+H]+

MAP-7

ERENEK

803.38

[M+H]+

MAP-7

YEAAIQR

849.43

[M+H]+

MAP-7

SREEAER

875.41

[M+H]+

MAP-7

EEAEARSR

946.45

[M+H]+

MAP-7

SVHRCAPAGER (CAM)

1239.60

[M+2H]+2
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Appendix 3
Details of nESI/TIMS hardware and mobility calibration
Nano-ESI source
Custom nESI emitters were made from quartz glass capillaries (I.D. 0.7 mm, O.D. 1.0
mm) utilizing a P-2000 micropipette laser puller (Sutter Instruments, Novato, CA). The
inlet capillary was a stainless steel tube (1/16 × 0.020ʺ, IDEX Health Science, Oak
Harbor, WA).

TIMS cell
The TIMS cell is an electrodynamic ion funnel with three regions (see scheme below):
entrance, analyzer tunnel (46 mm length), and exit. The rf voltage creates a quadrupolar
field in the tunnel and dipolar field in other regions.

Mobility calibration in TIMS as described in reference 50
Multiple ion species are first trapped and thermalized at different E values set up by
voltage profile along the tunnel, then pushed out by “ramping” (decreasing) E in steps

195

with each species eluting at a characteristic voltage (Velution - Vout). The total time an ion
spends in the system (from gating into the TIMS cell to registration at the ToF detector)
is:
ttotal = ttrap + (Velution/Vramp) × tramp + tToF = t0 + (Velution/Vramp) × tramp,

where ttrap is the trapping time, tToF is the flight time from cell exit to detector (through
MS vacuum), Vramp and tramp are the voltage range and time of ramp, and t0 is the time
before and after the separation step. The Velution and t0 values are determined
simultaneously by varying tramp from 100 to 500 ms at fixed Vramp as a function of the m/z
of interest
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Appendix 3.1
Collision cross sections (CCS, Å²) and resolving power (R) values for protonated histone
tails measured using TIMS.
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Appendix 3.2
Relative (approximate) cross sections for K9ac (dominant peaks). Lines guide the eye
through trends below and above the transition region.

Relative

(1.0 for z = 6)

1.5

K9ac

1.4

TWIMS

1.3
1.2

TIMS

1.1
1.0
0.9
6

8

200

z

10

12

Appendix 3.3
TWIMS spectra for selected mixtures of me3, p, and me variants measured in N2 using
solvent (i) (solid black lines) with fits by scaled individual traces from Fig. 1 (colored
lines) and their computed additions (dotted lines).
(a) K4me3/K9me3

(b) K4me3/K23me3
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(c) K4me3/K36me3

(d) K27me3/K36me3

(e) T6p/S10p

202

(f) K4me/K23me
K4me/K23me

Appendix 3.4
TWIMS spectra for selected variant mixtures measured in N2 with solvent (i) using the
traveling wave speeds of 650, 1000, and 1900 m/s.
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Appendix 3.4 (continued)
K4me3/K23me3 8+

K4me3/K23me3 9+
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K4me3/K36me3 8+

Appendix 3.4 (continued)
K27me3/K36me3 8+

T6p/S10p
10+
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K4me/K23me
8+

Appendix 3.5
Pairwise linear correlations between transit times for ac and me3 variants at the traveling
wave speeds of 650 and 1000 m/s. Variants with only three data points and p variants
with partial data at s = 1000 m/s are not included.
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Appendix 3.6
TWIMS spectra measured with different ESI solvents: (a) four me3 variants (z = 9) with
solvents (i, ii, iii), (b) K23me3 (z = 8 and 9) with solvents (i, iv).

(a)

(b)

207

Appendix 3.7
TWIMS spectra for four me3 variants in z = 12 measured in N2 using solvent (ii) and s =
650 m/s. No signal at 12+ was found for the K4me3 variant.
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Appendix 3.8
TIMS spectra (on the cross section scale) measured for exemplary me3, ac, p, and me
variant species using (a) tramp = 100 - 500 ms from MeOH/H2O solutions, (b) from
MeOH/H2O and aqueous solutions.
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Appendix 3.9
TIMS spectra for selected mixtures of p variants and traces for the two components.
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Appendix 3.10
Linear correlations between transit times for me3, ac, and p variants across charge state
pairs (major peaks from Fig. 1). Variants for me (with three data points) are not included.
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Appendix 3.11
Linear correlations between separation parameters in TIMS for the acetylated and
phosphorylated peptide variants in different charge states.
Acetylated
1305

6/7

r2 = 0.00

6/10

r2 = 0.35

1300

1295

1290

7/10 r2 = 0.03

CCS, A2

1710

1700

1690
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r2 = 0.68 7/11
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10/11

1785

r2 = 0.05

1780

r2 = 0.29
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1690

1700
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1720

CCS, A2

Phosphorylated

1410

6/7

1400

1390

r2 = 0.48

1380
1860

r2 = 0.02

6/10

7/10
r2 = 0.24

CCS, A2

1840

1820
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10/11
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1920
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r2 = 0.00

1890

r2 = 0.46

2

r = 0.25
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1270
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1290

1300

1310

1320

1380

1390

1400

1410

CCS, A2
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1790

1800

1810

1820
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1850

1860

Appendix 3.12
Linear correlations between separation parameters in Synapt and TIMS for the acetylated
and phosphorylated peptide variants.
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Appendix 3.13
Linear correlations between FAIMS and TIMS (left column) or TWIMS (right column)
separations for (a) acetylated and (b) phosphorylated variants, r2 marked. To facilitate
comparison, the left column in (a) repeats the data from Fig. 6 in the text.
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Appendix 3.14
Linear correlations between FAIMS and TIMS (left) or TWIMS (right) separations for
same acetylated (a) and phosphorylated (b) variants with different charge states selected
in the two dimensions (r2 marked).
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Appendix 5.1
TIMS profiles as a function of the desolvation time for [M-5H]-5 i-motif DNA.
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Appendix 5.2
TIMS profiles as a function of the desolvation time for [M-6H]-6 i-motif DNA.
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Appendix 5.3
TIMS profiles as a function of the desolvation time for [M-7H]-7 i-motif DNA.

[M-7H]-7
100 ms

200 ms

300 ms

400 ms

500 ms

800

1000

1200

CCS (Å)2

220

1400

1600

Appendix 5.4
TIMS profiles as a function of the desolvation time for [M-8H]-8 i-motif DNA.
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Appendix 5.5
TIMS profiles as a function of the desolvation time for [M-9H]-9 i-motif DNA.
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Appendix 6.1
Typical mass spectrum of 1:1 ATPH:DNA complex (left panel) and 2:1 ATHP:DNA
complex (right panel).
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Appendix 6.2
Collision induced dissociation curves for the +5 charge state of FL876 complexed with
ATHP 1 and 2 (charge state and degrees of freedom were considered).
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Appendix 6.3
Fluorescent measurements for DNA (FL876) and Hoescht 33258 dye titrated with ATHP
1, ATHP 2 or ATHP 3.
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Appendix 7.1
ATHP3 single amino acid substitutions considered and their nomenclature.
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Appendix 7.2
Schematic diagram of the TIMS cell used to trap and separate ions based on differences
in each species ion neutral collision cross section.
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Appendix 7.3
Typical, normalized ATHP3 and variant mobility profiles for the [M+H]+, [M+2H]2+ and
[M+3H]3+(a). Peptide IMS fingerprint (b) and correlation matrix (c) are used for
assessment of the primary sequence effect on the secondary structure
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Appendix 7.4
Typical ion mobility profiles (a) of the native and substituted ATHP3 : DNA complexes.
The IMS profile fingerprint (b) of the complexes was used to generate a correlation
matrix (c).

229

Appendix 8.1
(a)Typical mass spectra of all charge states observed under native starting solvent
conditions, and (b) the mobility profiles for the native (+10 to +13), partially folded (+13
to +21) and unfolded forms (+21 to +35) of unbound vTopIB. The structure presented is
a modified version pdb 3IGC, without the DNA substrate.
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